Voice disturbances

R18_VOICE_DISTU

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R49 Hospital discharge: ICD-9 — 7844 Cause of death: ICD-10 — R49 Cause of death: ICD-9 — 7844 2 out of 7 registries used, show all original rules.	14200
4. Check minimum number of events None	14200
5. Include endpoints None	14200
6. Filter based on genotype QC (FinnGen only)	12770

Control definitions (FinnGen only)

Control exclude: R18_SYMPTOMS_SIGNS_INVOLVI_SPEECH_VOICE

Extra metadata

Level in the ICD hierarchy: 3
Special: VOICERESO
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R47-R49
Name in latin: Perturbationes vocis

NAME	R18_VOICE_DISTU
CONTROL_EXCLUDE	R18_SYMPTOMS_SIGNS_INVOLVI_SPEECH_VOICE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R49
HD_ICD_9	7844
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R49
COD_ICD_9	7844
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Voice disturbances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12770	8777	3993
Unadjusted period prevalence (%)	2.71	3.12	1.83
Median age at first event (years)	57.50	53.91	65.39

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
13198: Matched controls
131980

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R05

ICD-10 Finland

Cough

2.2

321.3

3718

20065

R49.02

ICD-10 Finland

Spasmodic dysphonia

+∞

319.0

305

R06.0

ICD-10 Finland

Dyspnoea

2.1

311.0

4365

25307

R03BA05

ATC

fluticasone; inhalant

2.3

309.8

3061

15462

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.7

308.3

1961

8104

R23

ICPC

Voice symptom/complaint

11.9

307.7

1198

1100

Z50.5

ICD-10 Finland

Speech therapy

22.2

307.7

780

373

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

9.5

307.7

696

769

R49.0

ICD-10 Finland

Dysphonia

32.6

307.7

2029

731

R49

ICD-10 Finland

Voice disturbances

55.1

307.7

328

R49.8

ICD-10 Finland

Other and unspecified voice disturbances

137.4

307.7

1784

150

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

12.0

307.7

341

291

H02AB06

ATC

prednisolone; systemic

2.1

307.7

7289

49168

J37.0

ICD-10 Finland

Chronic laryngitis

11.4

307.7

1696

1692

J45.0

ICD-10 Finland

Predominantly allergic asthma

3.0

307.7

1751

6376

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

10.6

307.7

372

360

R49.09

ICD-10 Finland

Unspecified dysphonia

128.3

307.7

1563

138

RL210, ,

NOMESCO Finland

41.6

307.7

317

R03AK08

ATC

formoterol and beclometasone; inhalant

3.9

307.7

1094

3008

A02BC05

ATC

esomeprazole; systemic

2.5

307.7

7036

41037

J45.1

ICD-10 Finland

Nonallergic asthma

3.2

307.7

1501

5014

R03BA02

ATC

budesonide; inhalant

2.3

307.7

3099

15427

J38.2

ICD-10 Finland

Nodules of vocal cords

20.4

307.7

325

163

J04.0

ICD-10 Finland

Acute laryngitis

5.1

307.7

1020

2114

R4130

NOMESCO Finland

Speech therapy

12.2

307.7

1223

1099

R03DC03

ATC

montelukast; oral

3.0

307.7

3528

14203

R03AC02

ATC

salbutamol; inhalant

2.4

307.7

8712

58594

R49.01

ICD-10 Finland

Functional dysphonia

1103.5

307.7

6045

101

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.6

307.7

3579

16600

Z3226

NOMESCO Finland

Physiotherapist

2.4

307.7

3061

14847

UDQ12

NOMESCO Finland

Flexible laryngoscopy

11.6

307.7

2997

3247

R49.03

ICD-10 Finland

Atrophic dysphonia

960.1

307.7

1892

J38.3

ICD-10 Finland

Other diseases of vocal cords

14.3

307.7

534

388

R01AD09

ATC

mometasone; nasal

2.1

307.7

7011

46693

J45

ICD-10 Finland

Asthma

2.8

307.7

2113

8421

R49.1

ICD-10 Finland

Aphonia

66.4

307.7

368

J45.9

ICD-10 Finland

Asthma, unspecified

2.7

307.7

3759

16788

R13

ICD-10 Finland

Dysphagia

3.4

307.7

1520

4836

R49.08

ICD-10 Finland

Other specified dysphonia

457.1

307.7

4122

131

R03BA08

ATC

ciclesonide; inhalant

3.9

307.7

2245

6569

A02BC02

ATC

pantoprazole; systemic

2.2

307.3

9955

77417

R03BB04

ATC

tiotropium bromide; inhalant

2.8

305.2

1784

7060

UDQ02

NOMESCO Finland

Direct laryngoscopy

11.1

290.2

310

286

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

289.1

4547

27320

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.4

287.4

2388

11161

J38.4

ICD-10 Finland

Oedema of larynx

16.2

285.4

243

153

R96

ICPC

Asthma

2.6

284.8

1904

8043

UDH02

NOMESCO Finland

Rhinopharyngoscopy

3.1

275.3

1275

4432

A02BC03

ATC

lansoprazole; oral

2.0

274.9

4385

26378

R47.1

ICD-10 Finland

Dysarthria and anarthria

91.6

259.9

136

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

7.5

258.2

373

508

R03AC13

ATC

formoterol; inhalant

3.3

253.6

1012

3214

R03AK07

ATC

formoterol and budesonide; inhalant

2.0

247.1

3397

19261

R03BA01

ATC

beclometasone; inhalant

2.2

243.2

2339

11559

A02BC01

ATC

omeprazole; systemic

1.9

242.6

4083

24802

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

240.4

3591

20933

J31.0

ICD-10 Finland

Chronic rhinitis

2.6

236.9

1566

6545

J01FA10

ATC

azithromycin; systemic

1.8

233.0

8063

60983

R01AD08

ATC

fluticasone; nasal

1.9

229.0

4277

26775

R01AD12

ATC

fluticasone furoate; nasal

1.9

226.3

4668

30128

R21

ICPC

Throat symptom/complaint

2.0

226.3

3204

18274

R01AD58

ATC

fluticasone, combinations; nasal

1.9

220.5

3822

23302

R06AX27

ATC

desloratadine; oral

1.9

219.7

4310

27330

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.8

211.7

5395

36913

R03AC03

ATC

terbutaline; inhalant

2.2

210.8

2224

11347

J01AA02

ATC

doxycycline; systemic

2.0

210.4

10675

89462

A02BC04

ATC

rabeprazole; oral

2.5

209.2

1537

6731

RP210, ,

NOMESCO Finland

26.8

208.9

143

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

205.0

4135

26328

J02AC01

ATC

fluconazole; systemic

1.7

204.7

5959

42230

J38.7

ICD-10 Finland

Other diseases of larynx

10.0

203.6

233

237

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

202.3

3998

25275

R05

ICPC

Cough

1.8

200.0

3833

23990

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

199.9

6951

51638

J01FA06

ATC

roxithromycin; oral

1.7

199.1

5582

39047

M79.6

ICD-10 Finland

Pain in limb

1.7

198.8

6436

46852

Z2221

NOMESCO Finland

Medical doctor

1.8

195.8

3944

25031

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.7

193.0

1087

4177

DQE10

NOMESCO Finland

Injection of foreign material into vocal cord

16.3

190.2

161

100

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

189.9

6556

48346

XQ800

NOMESCO Finland

Prick test

2.5

189.4

1263

5275

R06AE07

ATC

cetirizine; oral

1.7

182.0

6205

45420

R07.0

ICD-10 Finland

Pain in throat

2.5

181.3

1252

5312

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

178.7

2890

17048

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

178.6

4406

29500

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

177.9

6172

45291

R02

ICPC

Shortness of breath/dyspnoea

2.0

174.9

2148

11529

UDQ22

NOMESCO Finland

Microlaryngoscopy

8.4

170.7

224

272

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

170.6

1607

7792

R03AK11

ATC

formoterol and fluticasone; inhalant

3.9

169.5

520

1383

J46

ICD-10 Finland

Status asthmaticus

3.6

169.2

592

1722

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

168.3

5161

36501

M25.5

ICD-10 Finland

Pain in joint

1.7

166.6

4799

33361

R4110

NOMESCO Finland

Physiotherapy

1.7

164.2

3915

25835

Z71.8

ICD-10 Finland

Other specified counselling

1.7

163.7

4852

33944

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

161.8

3661

23787

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

5.9

161.0

290

497

N03AX16

ATC

[U] pregabalin

1.8

159.2

3301

20904

R03AC12

ATC

salmeterol; inhalant

2.9

156.8

759

2683

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

156.4

805

2942

R53

ICD-10 Finland

Malaise and fatigue

1.7

155.3

3615

23627

R51.80

ICD-10 Finland

Headache

1.9

154.7

2335

13398

N02AX02

ATC

tramadol; systemic, rectal

1.6

154.0

5801

42928

M54.5

ICD-10 Finland

Low back pain

1.6

151.2

5131

36951

L17

ICPC

Foot/toe symptom/complaint

1.7

150.6

4418

30661

J01FA09

ATC

clarithromycin; systemic

1.7

149.8

4309

29744

G44.2

ICD-10 Finland

Tension-type headache

1.9

149.5

2111

11836

R42

ICD-10 Finland

Dizziness and giddiness

1.7

146.1

3318

21475

H02AB04

ATC

methylprednisolone; systemic

1.9

145.8

2130

12069

M03BX02

ATC

tizanidine; oral

1.6

145.2

8328

67793

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

142.1

6959

54437

ZXE00

NOMESCO Finland

One hour or less

1.6

140.9

5147

37555

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.6

139.7

844

3346

R74

ICPC

Upper respiratory infection acute

1.6

138.7

4483

31720

H02AB07

ATC

prednisone; oral

1.9

138.3

1947

10881

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

18.6

137.6

109

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

135.9

1218

5762

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.5

135.4

476

1387

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

134.3

2638

16331

N03AX12

ATC

[U] gabapentin; oral

1.8

134.2

2302

13689

R03BC03

ATC

nedocromil; inhalant

2.3

132.9

1081

4909

L03

ICPC

Low back symptom/complaint

1.6

132.7

4121

28802

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

131.5

3373

22452

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

130.9

2832

18001

Z3231

NOMESCO Finland

Registered nurse

1.7

130.5

3597

24379

L01

ICPC

Neck symptom/complaint

1.8

126.8

2417

14805

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

125.6

4130

29183

G47.3

ICD-10 Finland

Sleep apnoea

1.7

124.2

3033

19882

A02BA02

ATC

ranitidine; systemic

1.7

122.8

2542

15925

DQD34

NOMESCO Finland

Treatment of spasmodic dysfonia

184.6

122.7

128

N06AX11

ATC

mirtazapine; oral

1.6

121.5

4603

33555

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

121.5

1362

7011

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.0

121.4

1483

7873

BAA60

NOMESCO Finland

Total thyroidectomy

3.3

120.0

473

1481

J01DB01

ATC

cefalexin; oral

1.7

118.5

10897

96715

R03DA04

ATC

theophylline; systemic, rectal

2.6

117.1

713

2833

R01AD01

ATC

beclometasone; nasal

1.8

116.7

2122

12788

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

115.7

5751

44367

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

115.5

1827

10553

DQA10

NOMESCO Finland

Biopsy of larynx

8.2

115.0

153

189

C01CA24

ATC

epinephrine; parenteral

2.3

114.1

942

4297

UJF32

NOMESCO Finland

Coloscopy

1.6

113.3

3518

24399

R83

ICPC

Respiratory infection other

1.6

112.9

3354

23011

H03AA01

ATC

levothyroxine sodium; systemic

1.6

111.7

3293

22539

J01CA04

ATC

amoxicillin; systemic

1.7

111.6

10673

94611

R47.0

ICD-10 Finland

Dysphasia and aphasia

21.7

110.6

F45.8

ICD-10 Finland

Other somatoform disorders

2.2

110.6

1021

4873

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

110.6

4586

33929

S18

ICPC

Laceration/cut

1.5

110.4

6205

48944

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.6

109.6

657

2589

A11

ICPC

Chest pain NOS

2.0

109.6

1278

6661

R06AE09

ATC

levocetirizine; oral

1.8

109.4

1981

11904

E0000UV, ,

ATC

1.5

109.3

5540

42742

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

6.7

108.9

173

261

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

107.8

1850

10936

R52.9

ICD-10 Finland

Pain, unspecified

1.9

107.7

1536

8572

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

107.3

5653

43908

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

106.6

4795

36024

R06AX22

ATC

ebastine; oral

1.7

106.6

2377

15130

J45.8

ICD-10 Finland

Mixed asthma

2.9

105.7

518

1838

N06AX21

ATC

duloxetine; oral

1.8

104.6

1723

10054

J20

ICD-10 Finland

Acute bronchitis

1.9

104.1

1512

8481

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

103.8

3653

25982

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

103.1

4589

34338

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

102.1

3441

24216

R1260

NOMESCO Finland

Evaluation of communicative skills

4.2

102.0

272

652

S29

ICPC

Skin symptom/complaint other

1.6

101.7

2818

18933

A07AA02

ATC

nystatin; oral

2.2

101.0

862

3982

N02BE01

ATC

paracetamol; systemic, rectal

1.9

100.9

11829

108584

R01AD05

ATC

budesonide; nasal

2.1

100.8

1080

5451

K30

ICD-10 Finland

Functional dyspepsia

1.8

99.9

1658

9687

AA1AD

NOMESCO Finland

CT of head and brain

1.5

99.0

3666

26314

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.0

98.2

1199

6340

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

96.4

5061

39019

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

96.2

2967

20413

D01

ICPC

Abdominal pain/cramps general

1.8

95.9

1727

10328

J01DA01

ATC

[U] cefalexin

1.5

95.9

7866

66092

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

95.2

9282

80654

M01AH05

ATC

etoricoxib; oral

1.5

94.7

8144

68973

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

94.4

1499

8631

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

94.3

3280

23173

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.1

94.3

903

4364

GD1AA, ,

SPAT

1.7

94.2

2157

13779

L12

ICPC

Hand/finger symptom/complaint

1.6

94.2

2382

15609

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

93.1

2499

16615

K07.60

ICD-10 Finland

Snapping jaw

2.2

92.6

785

3613

R12

ICD-10 Finland

Heartburn

1.9

92.5

1235

6727

R07.3

ICD-10 Finland

Other chest pain

1.8

91.5

1442

8280

R49.2

ICD-10 Finland

Hypernasality and hyponasality

894.9

90.9

J01MA02

ATC

ciprofloxacin; systemic

1.5

88.5

4858

37599

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.0

88.3

1003

5164

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

87.7

1390

7989

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

87.1

826

3974

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

86.8

987

5083

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

86.6

2891

20177

L08

ICPC

Shoulder symptom/complaint

1.5

86.4

3082

21827

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

85.8

754

3519

Z01.7

ICD-10 Finland

Laboratory examination

1.6

85.7

2253

14868

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.8

85.4

1504

8917

A04

ICPC

Weakness/tiredness general

1.6

84.8

2103

13674

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

84.7

5459

43434

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

84.3

1801

11267

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

84.3

1022

5381

M01AE02

ATC

naproxen; oral, rectal

1.4

83.7

7150

59803

R20.2

ICD-10 Finland

Paraesthesia of skin

2.0

83.6

1027

5431

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

83.3

1857

11744

R06AX13

ATC

loratadine; oral

1.7

83.1

1940

12416

UJC01

NOMESCO Finland

Scopy of lower throat

4.8

83.0

187

392

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.4

82.5

566

2374

N05CF01

ATC

zopiclone; oral

1.5

82.1

4018

30305

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.6

82.0

498

1972

J38.5

ICD-10 Finland

Laryngeal spasm

10.3

81.7

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

80.9

8509

73653

M01AB05

ATC

diclofenac; systemic, rectal

1.4

80.9

8391

72450

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.5

80.7

509

2053

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

80.4

1629

10035

Z01.2

ICD-10 Finland

Dental examination

1.4

80.4

6001

48859

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.9

80.3

398

1420

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

79.9

1887

12103

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

79.9

7013

58721

C07AA05

ATC

propranolol; systemic

1.6

79.5

2586

17898

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

79.3

2286

15392

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.7

79.3

437

1649

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

79.1

779

3801

A97

ICPC

No disease

1.5

77.8

2603

18119

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

7.1

77.6

116

164

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

77.6

503

2055

N02BF01

ATC

gabapentin; oral

1.7

77.5

1437

8633

M54.2

ICD-10 Finland

Cervicalgia

1.9

77.4

1120

6246

ZXA10

NOMESCO Finland

Bilateral

1.6

77.3

2322

15771

N17

ICPC

Vertigo/dizziness

1.7

77.2

1726

10907

M79.1

ICD-10 Finland

Myalgia

1.6

77.1

1991

13046

P06

ICPC

Sleep disturbance

1.7

77.1

1712

10799

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.4

76.3

533

2253

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

76.1

5190

41454

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

76.0

9143

80572

M02AA07

ATC

piroxicam; topical

1.4

75.9

4424

34360

R03DC01

ATC

zafirlukast; oral

3.4

75.8

277

827

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

75.8

3738

28142

P01AB01

ATC

metronidazole; oral, rectal

1.4

75.5

5179

41391

ZXA00

NOMESCO Finland

Right side

1.5

75.5

3197

23360

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.0

74.9

334

1124

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

74.4

1211

7000

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

74.1

2501

17416

ZXD20

NOMESCO Finland

Day surgery

1.7

74.1

1618

10154

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

73.6

1900

12438

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

73.6

582

2598

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

73.4

2562

17967

SFA10

NOMESCO Finland

One-surface restoration

1.4

73.4

6928

58357

N01

ICPC

Headache

1.7

73.4

1427

8680

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

73.3

4814

38123

A01AB09

ATC

miconazole; local oral

1.8

72.6

1125

6405

104

Kela drug reimbursment

Thyroid insufficiency

1.9

72.4

997

5468

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

72.1

4482

35129

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

71.9

2336

16119

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

71.7

1272

7537

G04BD12

ATC

mirabegron; oral

1.7

71.7

1587

9991

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

71.2

1294

7720

S21

ICPC

Skin texture symptom/complaint

1.6

71.2

1999

13343

J01DA06

ATC

[U] cefuroxime

1.6

70.9

1786

11612

R4120

NOMESCO Finland

Occupational therapy

2.0

70.9

868

4577

D19

ICPC

Teeth/gum symptom/complaint

1.4

70.9

3906

29938

C07AB07

ATC

bisoprolol; oral

1.4

70.7

5903

48595

R03BB01

ATC

ipratropium bromide; inhalant

2.5

70.7

475

1972

WX002

NOMESCO Finland

Sedation and analgesia

1.5

70.7

2382

16563

R35

ICD-10 Finland

Polyuria

2.0

70.4

874

4631

J30.3

ICD-10 Finland

Other allergic rhinitis

2.4

70.0

508

2184

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

69.8

717

3550

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

69.8

1660

10638

R01AD11

ATC

triamcinolone; nasal

1.8

69.5

1125

6487

ZXA05

NOMESCO Finland

Left side

1.5

69.4

2941

21432

N03AE01

ATC

clonazepam; systemic

2.0

69.3

757

3834

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

69.3

5772

47445

A03FA02

ATC

cisapride; oral, rectal

1.9

69.3

955

5238

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

68.9

705

3486

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

68.8

1722

11174

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

68.7

866

4611

A01

ICPC

Pain general/multiple sites

1.7

68.0

1362

8343

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

67.9

494

2126

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

67.9

1359

8322

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.7

67.8

1302

7884

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

67.5

3376

25372

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

67.5

521

2301

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.4

67.5

6290

52571

L13

ICPC

Hip symptom/complaint

1.5

66.9

2591

18522

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

66.8

2169

14939

N05CF02

ATC

zolpidem; oral

1.5

66.5

2207

15272

XF402

NOMESCO Finland

ECG with work load test

1.7

66.3

1279

7751

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.4

66.0

475

2034

XKD00

NOMESCO Finland

Uroflowmetry

1.6

65.8

1645

10662

UDC00

NOMESCO Finland

Ear microscopy

1.9

65.5

947

5272

M48.0

ICD-10 Finland

Spinal stenosis

1.6

65.1

1542

9859

F29

ICPC

Eye symptom/complaint other

1.7

65.0

1416

8863

D06

ICPC

Abdominal pain localized other

1.7

64.9

1219

7330

M01AC06

ATC

meloxicam; systemic, rectal

1.4

64.6

4499

35776

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

3.4

64.3

239

721

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.6

64.3

1798

11963

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

64.1

2283

16023

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.7

64.1

360

1371

RL130, ,

NOMESCO Finland

11.0

64.1

M01AH01

ATC

celecoxib; oral

1.5

64.0

2244

15698

R29

ICPC

Respiratory symptom/complaint other

1.9

63.9

911

5047

J01FF01

ATC

clindamycin; systemic

1.4

63.8

3301

24918

N06AA09

ATC

amitriptyline; systemic

1.7

63.3

1223

7411

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

63.1

1098

6460

UKC02

NOMESCO Finland

Cystoscopy

1.6

63.1

1823

12218

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

62.8

3051

22753

U07

ICPC

Urine symptom/complaint other

1.7

62.8

1152

6881

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

62.7

1045

6072

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

62.5

5938

49549

RL230, ,

NOMESCO Finland

313.6

62.4

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

62.4

2335

16549

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.6

62.1

1460

9311

G24.8

ICD-10 Finland

Other dystonia

7.1

62.0

132

U02

ICPC

Urinary frequency/urgency

1.5

62.0

1996

13702

D11

ICPC

Diarrhoea

1.6

61.6

1515

9769

R4130, ,

SPAT

7.0

61.6

133

A98

ICPC

Health maint/preventive medicine

2.2

61.5

12757

122505

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

61.5

3607

27807

L28

ICPC

Limited function/disability (L)

1.5

61.2

2363

16847

J05AB01

ATC

aciclovir; systemic

1.5

60.9

2765

20343

J01FA15

ATC

telithromycin; oral

1.7

60.9

1244

7650

R06.5

ICD-10 Finland

Mouth breathing

1.8

60.8

1077

6365

D07AC01

ATC

betamethasone; topical

1.4

60.3

4477

35868

KMAK, ,

NOMESCO Finland

1.4

60.1

6208

52347

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

60.1

1026

6001

L15

ICPC

Knee symptom/complaint

1.4

60.0

3239

24590

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

6.1

60.0

104

172

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.9

59.9

279

962

SPAT1058

SPAT

PEF monitoring instruction

1.8

59.9

1024

5992

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

59.7

1578

10351

J34.2

ICD-10 Finland

Deviated nasal septum

2.1

59.4

621

3093

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

59.3

1240

7669

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

59.1

1174

7161

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

59.1

1762

11881

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

59.1

896

5058

R52.2

ICD-10 Finland

Other chronic pain

2.2

58.9

525

2460

N05BA04

ATC

oxazepam; oral

1.4

58.8

3242

24685

SFA20

NOMESCO Finland

Two-surface restoration

1.3

58.4

7255

62781

WX402

NOMESCO Finland

General anaesthesia

1.4

58.4

2790

20701

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

58.0

3096

23432

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

3.3

58.0

218

663

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.7

57.7

1250

7799

L02

ICPC

Back symptom/complaint

1.6

57.6

1331

8442

DHB50

NOMESCO Finland

Turbinoplasty

2.6

57.3

339

1325

K08.80

ICD-10 Finland

Toothache NOS

1.7

57.2

1161

7121

1420

FHL

Laryngomicroscopy

5.0

57.2

124

252

M01AX17

ATC

nimesulide; oral

1.4

57.0

2854

21343

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

56.9

4604

37298

R51

ICD-10 Finland

Headache

1.9

56.8

740

3979

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

56.4

2649

19575

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

56.3

2794

20854

N06AX16

ATC

venlafaxine; oral

1.5

56.1

1762

12006

R04.2

ICD-10 Finland

Haemoptysis

2.3

56.0

429

1888

X58

ICD-10 Finland

Exposure to other specified factors

1.5

55.9

1749

11907

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

55.6

1318

8409

N04BC05

ATC

pramipexole; oral

1.8

55.5

958

5615

M79.7

ICD-10 Finland

Fibromyalgia

2.1

55.3

528

2542

R06AX26

ATC

fexofenadine; oral

1.8

54.5

878

5043

J01EA01

ATC

trimethoprim; systemic

1.4

54.4

3260

25124

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

54.1

647

3380

A01AB04

ATC

amphotericin B; local oral

2.0

53.8

584

2947

J01MA06

ATC

norfloxacin; oral

1.5

53.4

1614

10895

K80

ICPC

Cardiac arrhythmia NOS

1.7

53.3

1122

6943

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.6

53.0

1520

10139

SDA03

NOMESCO Finland

Periodontal treatment

1.3

52.9

5032

41639

R01AD59

ATC

mometasone, combinations; nasal

1.8

52.8

831

4741

K59.0

ICD-10 Finland

Constipation

1.9

52.7

724

3958

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.7

52.6

166

450

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

52.5

2166

15590

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.4

52.4

3673

29006

EB1AA, ,

SPAT

1.8

51.7

810

4612

N06AB10

ATC

escitalopram; oral

1.4

51.6

2424

17875

M01AH02

ATC

rofecoxib; oral

1.6

51.6

1505

10077

J02AC02

ATC

itraconazole; systemic

1.5

51.3

2181

15781

J05AB11

ATC

valaciclovir; oral

1.5

51.2

1841

12887

G04CA02

ATC

tamsulosin; oral

1.5

51.2

2186

15833

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.5

50.8

2089

15017

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

50.5

1030

6318

C09CA06

ATC

candesartan; oral

1.4

50.4

2974

22810

H92.0

ICD-10 Finland

Otalgia

1.8

50.4

814

4678

J01MA14

ATC

moxifloxacin; systemic

1.7

49.7

1071

6662

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

49.7

3347

26216

R06.2

ICD-10 Finland

Wheezing

2.0

49.7

568

2919

M01AX05

ATC

glucosamine; oral

1.4

49.7

2254

16502

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

49.7

402

1811

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

49.6

597

3123

K02.1

ICD-10 Finland

Caries of dentine

1.3

49.4

7156

62589

J37

ICD-10 Finland

Chronic laryngitis and laryngotracheitis

14.1

49.3

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

3.8

49.1

150

398

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

49.0

1169

7461

RL390, ,

NOMESCO Finland

170.7

48.9

H01

ICPC

Ear pain/earache

1.6

48.9

1446

9705

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

48.6

3692

29446

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

48.6

1310

8608

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

48.5

1859

13169

S80.0

ICD-10 Finland

Contusion of knee

1.7

48.3

962

5862

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

48.3

756

4303

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

48.1

350

1506

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

2.8

48.0

236

839

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

47.9

2021

14587

RL330, ,

NOMESCO Finland

128.0

47.8

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

47.6

864

5132

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.2

47.6

434

2052

XF404

NOMESCO Finland

Ambulatory ECG

1.7

47.3

1001

6195

S04

ICPC

Lump/swelling localized

1.6

47.2

1363

9094

H02

ICPC

Hearing complaint

1.5

47.0

1783

12601

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

6.9

46.9

105

E04.1

ICD-10 Finland

Nontoxic single thyroid nodule

2.7

46.6

255

959

DFF00

NOMESCO Finland

Pure tone audiometry

1.6

46.4

1248

8190

ZX114

NOMESCO Finland

Intramuscular

3.0

46.3

209

709

J30.0

ICD-10 Finland

Vasomotor rhinitis

2.3

46.3

370

1658

D12

ICPC

Constipation

2.0

46.2

486

2424

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

46.2

952

5852

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

46.0

633

3461

J47

ICD-10 Finland

Bronchiectasis

2.7

46.0

248

926

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

45.8

2651

20215

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

45.7

2882

22292

N06AB04

ATC

citalopram; systemic

1.4

45.5

2464

18582

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

45.2

1130

7288

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

44.9

4289

35276

TAC00

NOMESCO Finland

Peripheral nerve block

5.3

44.9

171

L04

ICPC

Chest symptom/complaint

1.7

44.8

822

4896

XA402

NOMESCO Finland

ENMG

2.3

44.7

330

1429

J01MA12

ATC

levofloxacin; systemic

1.4

44.6

2106

15498

C05AA08

ATC

fluocortolone; rectal, topical

1.5

44.5

1592

11110

D07AC13

ATC

mometasone; topical

1.3

44.5

3401

27082

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

44.4

550

2906

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

44.4

2576

19642

H93.1

ICD-10 Finland

Tinnitus

1.7

44.3

863

5223

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.6

44.3

1176

7692

R00.2

ICD-10 Finland

Palpitations

1.6

44.3

1016

6417

N05AH04

ATC

quetiapine; oral

1.4

44.2

1980

14428

Z2446

NOMESCO Finland

Social worker

1.8

44.1

710

4072

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

44.0

1951

14189

M54.6

ICD-10 Finland

Pain in thoracic spine

1.7

43.9

929

5748

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

43.8

799

4750

H57.1

ICD-10 Finland

Ocular pain

2.0

43.8

507

2618

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

43.7

2723

20999

D03

ICPC

Heartburn

2.0

43.5

499

2567

XJC10

NOMESCO Finland

Oesophageal pH monitoring

4.6

43.4

102

222

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

43.4

572

3085

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

43.4

665

3760

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.7

43.4

862

5246

S82

ICPC

Naevus/mole

1.5

43.2

1731

12347

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.8

43.2

642

3595

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

43.2

3282

26087

J01DC02

ATC

cefuroxime; systemic

1.8

43.2

650

3655

SPAT1325

SPAT

Vaccination

1.3

42.8

3820

31075

H29

ICPC

Ear symptom/complaint other

1.5

42.7

1498

10406

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.5

42.7

1320

8930

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.9

42.5

199

689

L14

ICPC

Leg/thigh symptom/complaint

1.6

42.4

1008

6420

A29

ICPC

General symptom/complaint other

1.5

42.4

1625

11490

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.5

42.2

1588

11187

A03

ICPC

Fever

1.4

42.1

1969

14450

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

41.6

938

5894

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

41.5

3876

31694

L16

ICPC

Ankle symptom/complaint

1.5

41.3

1457

10130

L86

ICPC

Back syndrome with radiating pain

1.7

41.3

782

4697

N02BF02

ATC

pregabalin; oral

1.7

41.1

851

5232

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.0

40.9

452

2295

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

40.9

1189

7934

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

40.8

2396

18270

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

40.5

1006

6471

R60.0

ICD-10 Finland

Localized oedema

1.5

40.5

1525

10740

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

40.3

699

4097

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.4

40.2

1706

12289

D02

ICPC

Abdominal pain epigastric

1.7

40.2

787

4769

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.4

40.2

268

1110

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

40.1

715

4222

J04.2

ICD-10 Finland

Acute laryngotracheitis

4.0

40.1

115

292

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.0

40.0

421

2101

R50.9

ICD-10 Finland

Fever, unspecified

1.4

40.0

1711

12346

L57.0

ICD-10 Finland

Actinic keratosis

1.5

39.7

1236

8369

R49.04

ICD-10 Finland

Dysplastic dysphonia

+∞

39.6

U13

ICPC

Bladder symptom/complaint other

2.1

39.4

381

1842

L05

ICPC

Flank/axilla symptom/complaint

1.7

39.4

784

4770

UJD02

NOMESCO Finland

Gastroscopy

1.8

39.2

556

3069

R03AK03

ATC

[U] fenoterol and ipratropium bromide

1.9

39.1

521

2819

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

39.0

730

4368

ZXC10

NOMESCO Finland

Use of laser

2.4

39.0

270

1138

N05BA01

ATC

diazepam; systemic, rectal

1.5

38.9

1430

10015

R55

ICD-10 Finland

Syncope and collapse

1.5

38.9

1231

8360

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

38.9

824

5095

S06.0

ICD-10 Finland

Concussion

1.5

38.8

1208

8176

L29

ICPC

Musculoskeletal sympt/complt other

1.6

38.8

1107

7352

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.1

38.8

399

1975

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

38.5

1019

6651

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

38.5

1806

13242

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

38.4

482

2557

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

38.4

1136

7604

N30.0

ICD-10 Finland

Acute cystitis

1.4

38.4

2156

16305

R2110

NOMESCO Finland

Giving the first information

1.7

38.3

824

5114

C10AA07

ATC

rosuvastatin; oral

1.3

38.2

4004

33168

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

38.2

550

3049

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.6

38.2

230

908

R25.2

ICD-10 Finland

Cramp and spasm

2.2

37.9

322

1480

D06BX01

ATC

metronidazole; topical

1.5

37.8

1305

9023

TAB00

NOMESCO Finland

Lumbar puncture

1.9

37.7

518

2829

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

37.7

1221

8331

Z00.0

ICD-10 Finland

General medical examination

1.4

37.6

2209

16821

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

37.6

676

4001

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

37.5

3289

26584

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

37.5

447

2330

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.5

37.5

247

1017

XG405

NOMESCO Finland

Education on PEF monitoring

2.7

37.4

199

739

A06AC51

ATC

ispaghula, combinations; oral

1.8

37.3

581

3300

G04CA01

ATC

alfuzosin; oral

1.5

37.0

1085

7247

SHA04

NOMESCO Finland

Stomatognathic treatment, very demanding

2.9

37.0

177

621

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

36.9

917

5897

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

36.8

1894

14104

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.5

36.8

1239

8523

R63.4

ICD-10 Finland

Abnormal weight loss

1.9

36.5

481

2592

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

36.5

2564

20060

-1, ,

NOMESCO Finland

1.3

36.5

3721

30672

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.0

36.4

421

2172

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

36.4

412

2111

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

36.2

1535

11042

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

36.1

1528

10986

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

36.0

1817

13480

R09

ICPC

Sinus symptom/complaint

1.6

36.0

990

6518

R11

ICD-10 Finland

Nausea and vomiting

1.6

36.0

1004

6632

A99

ICPC

Disease/condition unspecnature/site

1.5

36.0

1234

8519

J04

ICD-10 Finland

Acute laryngitis and tracheitis

3.6

35.9

117

325

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.0

35.9

376

1873

N19

ICPC

Speech disorder

3.0

35.9

157

524

M54

ICD-10 Finland

Dorsalgia

1.5

35.9

1442

10268

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.8

35.6

516

2866

WX320

NOMESCO Finland

Spinalanesthesy

1.3

35.6

2883

23021

R03BC01

ATC

cromoglicic acid; inhalant

2.7

35.4

185

680

D07AA02

ATC

hydrocortisone; topical

1.4

35.4

1531

11048

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

35.4

309

1436

G24.3

ICD-10 Finland

Spasmodic torticollis

3.2

35.3

141

446

U05

ICPC

Urination problems other

1.7

35.2

619

3640

R4110, ,

SPAT

1.4

35.1

1638

11984

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

34.9

790

4964

G04BD08

ATC

solifenacin; oral

1.6

34.8

748

4640

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

34.8

3785

31419

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

34.7

3345

27337

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.1

34.6

328

1574

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

34.5

1418

10137

D21

ICPC

Swallowing problem

2.6

34.4

194

742

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

2.0

34.4

377

1910

Z50.1

ICD-10 Finland

Other physical therapy

1.7

34.4

611

3604

UJH02

NOMESCO Finland

Anoscopy

1.8

34.4

487

2687

GD1AD

NOMESCO Finland

Thorax CT examination

1.6

34.0

730

4526

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

3.5

34.0

117

337

G50.1

ICD-10 Finland

Atypical facial pain

2.4

34.0

244

1045

SPAT1297

SPAT

Other function in accordance with speech therapy nomenclature

5.6

34.0

115

J39.8

ICD-10 Finland

Other specified diseases of upper respiratory tract

4.7

34.0

167

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.9

33.9

457

2483

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

5.5

33.8

119

N06AA10

ATC

nortriptyline; systemic

2.3

33.8

264

1173

C10AA05

ATC

atorvastatin; oral

1.3

33.7

4817

41301

J35.0

ICD-10 Finland

Chronic tonsillitis

1.8

33.7

554

3197

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.0

33.7

396

2056

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.0

33.6

377

1926

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

33.5

1231

8609

K04

ICPC

Palpitations/awareness of heart

1.7

33.4

650

3928

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

33.4

11365

108035

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

33.2

1214

8482

P01

ICPC

Feeling anxious/nervous/tense

1.5

33.2

1328

9441

SFA30

NOMESCO Finland

Three-surface restoration

1.3

33.1

5005

43166

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

4.8

33.1

155

N06AB03

ATC

fluoxetine; oral

1.4

33.0

1388

9960

WX290

NOMESCO Finland

Other blockage of nerve

1.3

33.0

5440

47382

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

32.9

1096

7514

J01

ICD-10 Finland

Acute sinusitis

1.7

32.9

671

4108

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

32.8

691

4266

P03

ICPC

Feeling depressed

1.5

32.6

1087

7452

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.0

32.6

367

1877

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

32.5

787

5027

N39.3

ICD-10 Finland

Stress incontinence

1.5

32.5

943

6279

A06AD11

ATC

lactulose; oral

1.4

32.4

1523

11146

3AX01, ,

NOMESCO Finland

4.8

32.4

150

A23

ICPC

Risk factor NOS

1.5

32.3

1103

7600

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

32.3

839

5450

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.0

32.2

370

1905

WX734

NOMESCO Finland

JET-ventilation

7.6

32.2

U01

ICPC

Dysuria/painful urination

1.5

32.1

966

6481

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

31.9

852

5567

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

31.9

688

4271

RL430, ,

NOMESCO Finland

72.3

31.8

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

2.3

31.8

240

1051

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

31.8

361

1852

D07AB08

ATC

desonide; topical

1.5

31.7

1195

8397

DM1QA, ,

SPAT

1.8

31.7

487

2755

J06.0

ICD-10 Finland

Acute laryngopharyngitis

3.0

31.6

141

476

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

31.6

1199

8433

UJD10, ,

SPAT

2.0

31.6

330

1644

EP1AE, ,

SPAT

2.1

31.5

302

1456

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

31.4

591

3541

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

31.4

1054

7238

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

31.2

323

1604

SFA00

NOMESCO Finland

Small restoration

1.4

31.1

1615

12019

M02AA10

ATC

ketoprofen; topical

1.4

31.1

1808

13706

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.1

31.0

296

1425

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

30.9

486

2767

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.9

30.9

408

2201

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

30.9

1209

8553

E000001, ,

ATC

1.3

30.8

2169

16926

ZXC60

NOMESCO Finland

Application of heat

2.6

30.8

184

725

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.5

30.8

1010

6902

D01AE16

ATC

amorolfine; topical

1.4

30.7

1280

9162

C10AC01

ATC

colestyramine; oral

2.0

30.7

345

1763

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

30.7

1218

8640

XA800

NOMESCO Finland

Neuropsychological investigation

1.8

30.7

444

2466

PA6AD

NOMESCO Finland

CT of neck arteries

1.8

30.5

431

2377

R053, ,

ICD-10 Finland

1.9

30.4

422

2313

R15

ICD-10 Finland

Faecal incontinence

1.9

30.4

361

1881

S01GX02

ATC

levocabastine; ophthalmic

1.6

30.4

653

4050

M05BA04

ATC

alendronic acid; oral

1.5

30.4

967

6565

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

30.3

383

2037

N06AX26

ATC

vortioxetine; oral

1.6

30.3

838

5518

F01

ICPC

Eye pain

1.9

30.3

360

1876

S16

ICPC

Bruise/contusion

1.9

30.2

365

1912

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.9

30.2

394

2117

B37.0

ICD-10 Finland

Candidal stomatitis

2.7

30.0

160

595

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

29.9

1113

7798

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.3

29.9

236

1054

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

29.9

2638

21240

M03BX01

ATC

baclofen; systemic

2.3

29.8

229

1011

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

29.8

433

2408

D01BA02

ATC

terbinafine; oral

1.3

29.8

2788

22619

K03.80

ICD-10 Finland

Irradiated enamel

1.6

29.6

655

4092

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.1

29.6

278

1331

VALMI, ,

NOMESCO Finland

1.3

29.3

2643

21331

J01AA07

ATC

tetracycline; systemic

1.4

29.2

1588

11898

A08

ICPC

Swelling

1.6

29.1

672

4242

L95

ICPC

Osteoporosis

1.7

29.1

491

2854

N05BA12

ATC

alprazolam; oral

1.5

29.1

1093

7670

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.3

29.1

2535

20365

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

29.1

2195

17288

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

29.0

781

5112

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.5

29.0

1012

7000

K03.00

ICD-10 Finland

Approximal wear

1.5

29.0

876

5882

J01AA04

ATC

lymecycline; systemic

1.4

29.0

1402

10303

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

28.9

933

6350

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.1

28.9

288

1410

L11

ICPC

Wrist symptom/complaint

1.5

28.9

1085

7612

M77.4

ICD-10 Finland

Metatarsalgia

1.6

28.8

736

4759

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

28.7

566

3432

J01FA01

ATC

erythromycin; systemic

1.4

28.7

1475

10946

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.4

28.7

1793

13734

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.5

28.6

1045

7292

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

28.4

2150

16931

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

28.4

7976

73047

M01AB55

ATC

diclofenac, combinations; oral

1.6

28.4

722

4665

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

28.4

2673

21685

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

28.4

1443

10692

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.4

28.3

1332

9741

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

1.7

28.2

488

2858

7844C

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[DYSPHONIA FUNCTIONALIS ALIA]

+∞

28.1

7844L

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[RINOPHONIA SEU RHINOLALIA]

+∞

28.1

C01DA14

ATC

isosorbide mononitrate; oral

1.4

28.1

1478

11009

J01DA09

ATC

[U] cefadroxil

1.3

28.0

2939

24161

M02AA15

ATC

diclofenac; topical

1.5

27.9

787

5203

H01.0

ICD-10 Finland

Blepharitis

1.5

27.9

792

5245

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

27.9

1502

11232

J01DA08

ATC

[U] cefaclor

1.5

27.9

1080

7621

M01AC01

ATC

piroxicam; systemic, rectal

1.4

27.8

1407

10413

S22

ICPC

Nail symptom/complaint

1.6

27.8

770

5071

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

27.8

779

5145

SAA04

NOMESCO Finland

Special examination of mouth

1.7

27.7

560

3418

N06AB06

ATC

sertraline; oral

1.4

27.6

1224

8856

R5110, ,

SPAT

1.5

27.5

1006

7019

R1250

NOMESCO Finland

Evaluation of functional capability

2.0

27.5

288

1437

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

27.5

795

5287

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

27.4

837

5629

L20

ICPC

Joint symptom/complaint NOS

1.7

27.4

468

2730

WX892

NOMESCO Finland

Monitored bed care

1.5

27.3

780

5173

R51.81

ICD-10 Finland

Facial pain NOS

2.0

27.2

295

1489

E04.0

ICD-10 Finland

Nontoxic diffuse goitre

3.0

27.2

123

419

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.6

27.2

692

4469

Z00.8

ICD-10 Finland

Other general examinations

1.5

27.2

887

6048

A28

ICPC

Limited function/disability NOS

1.3

27.2

1915

14917

L50.9

ICD-10 Finland

Urticaria, unspecified

1.8

27.2

442

2542

G25.0

ICD-10 Finland

Essential tremor

2.0

27.2

308

1580

R52.0

ICD-10 Finland

Acute pain

1.9

27.2

374

2046

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.7

27.1

491

2910

R04

ICPC

Breathing problem other

1.8

27.0

449

2600

D06BB03

ATC

aciclovir; topical

1.7

27.0

530

3212

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

27.0

380

2094

A02BA04

ATC

nizatidine; systemic

1.5

27.0

787

5243

D82

ICPC

Teeth/gum disease

1.2

26.9

4268

36762

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.8

26.9

446

2581

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.5

26.7

808

5424

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

26.6

2063

16285

S12

ICPC

Insect bite/sting

1.5

26.6

987

6904

L19

ICPC

Muscle symptom/complaint NOS

1.9

26.6

347

1866

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

26.6

481

2851

Z2445

NOMESCO Finland

Psychologist

1.8

26.6

386

2147

SBB10

NOMESCO Finland

Dental impressions

1.6

26.5

685

4440

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

3.8

26.5

216

M77.1

ICD-10 Finland

Lateral epicondylitis

1.5

26.5

893

6130

J39.9

ICD-10 Finland

Disease of upper respiratory tract, unspecified

3.3

26.4

297

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

26.4

310

1610

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

26.4

657

4223

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

26.2

521

3168

N03AX09

ATC

lamotrigine; oral

1.7

26.1

497

2987

A92

ICPC

Allergy/allergic reaction NOS

1.9

26.0

346

1872

N02CC04

ATC

rizatriptan; oral

1.6

26.0

645

4141

H02AB09

ATC

hydrocortisone; systemic

2.0

26.0

267

1323

G04CB01

ATC

finasteride; oral

1.5

25.8

915

6344

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

25.8

817

5539

C10AX09

ATC

ezetimibe; oral

1.3

25.6

1832

14298

WX110, ,

SPAT

1.6

25.5

609

3874

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

25.5

2909

24112

R25.1

ICD-10 Finland

Tremor, unspecified

1.8

25.5

359

1977

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

25.5

490

2952

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

25.5

1473

11130

C08DA01

ATC

verapamil; systemic

1.7

25.5

429

2493

G43.3

ICD-10 Finland

Complicated migraine

2.2

25.4

211

963

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

3.3

25.4

280

N76.0

ICD-10 Finland

Acute vaginitis

1.5

25.4

703

4630

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.2

25.3

211

965

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

25.3

487

2936

T86

ICPC

Hypothyroidism/myxoedema

1.6

25.2

552

3439

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.0

25.2

272

1373

J39.2

ICD-10 Finland

Other diseases of pharynx

2.7

25.2

132

488

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

25.1

397

2266

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

3.3

25.1

287

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

25.1

806

5479

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

25.1

1366

10225

S22.3

ICD-10 Finland

Fracture of rib

1.5

25.1

735

4901

SPAT1153

SPAT

Removal of sutures

1.2

25.0

3481

29507

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

25.0

1457

11022

U71

ICPC

Cystitis/urinary infection other

1.5

25.0

827

5656

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.5

24.8

863

5960

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

24.8

606

3877

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

24.8

542

3376

E03

ICD-10 Finland

Other hypothyroidism

1.5

24.8

719

4784

EB1SA, ,

SPAT

1.6

24.7

561

3526

E000002, ,

ATC

1.4

24.7

1142

8317

R05DA01

ATC

ethylmorphine; oral

1.5

24.7

848

5843

P20

ICPC

Memory disturbance

1.4

24.7

1466

11123

UJC12

NOMESCO Finland

Flexible oesophagoscopy

3.1

24.7

104

341

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

24.6

1338

10008

D07AD01

ATC

clobetasol; topical

1.3

24.6

1915

15110

A91

ICPC

Abnormal result investigation NOS

1.6

24.5

594

3795

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

24.4

1029

7371

S01

ICPC

Pain/tenderness of skin

1.6

24.4

528

3281

R04.0

ICD-10 Finland

Epistaxis

1.5

24.4

776

5265

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.8

24.4

357

1992

N29

ICPC

Neurological sympt/complt other

2.1

24.3

219

1033

R4190

NOMESCO Finland

Nutritional therapy

1.7

24.3

421

2466

M54.8

ICD-10 Finland

Other dorsalgia

1.6

24.3

522

3238

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

1.8

24.3

334

1828

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

24.2

1036

7441

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

24.2

207

957

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

1.7

24.1

493

3019

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

2.0

24.0

274

1410

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.1

24.0

239

1172

J31.2

ICD-10 Finland

Chronic pharyngitis

3.1

23.9

311

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

23.9

1371

10343

G24.9

ICD-10 Finland

Dystonia, unspecified

4.2

23.9

151

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

23.9

757

5131

UDM02

NOMESCO Finland

Sinoscopy

2.0

23.9

246

1221

G04BD11

ATC

fesoterodine; oral

1.9

23.9

312

1680

M54.1

ICD-10 Finland

Radiculopathy

1.7

23.8

454

2729

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

23.8

1031

7418

G01AF05

ATC

econazole; vaginal

1.5

23.8

917

6458

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

23.8

493

3031

XG466

NOMESCO Finland

Sleep oxymetry

1.9

23.6

310

1671

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

23.6

608

3940

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.3

23.5

2404

19640

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

23.5

420

2483

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

23.4

1152

8477

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

23.4

2612

21567

L20.0

ICD-10 Finland

Besnier prurigo

1.5

23.4

740

5014

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

23.3

1624

12613

N05CD07

ATC

temazepam; oral

1.4

23.3

1139

8372

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

23.2

582

3747

J37.1

ICD-10 Finland

Chronic laryngotracheitis

9.7

23.2

U09.9

ICD-10 Finland

Post COVID-19 condition, unspecified

2.6

23.2

129

492

SPAT1260

SPAT

Consultation of another employee

1.3

23.1

1888

14985

N30

ICD-10 Finland

Cystitis

1.4

23.1

967

6918

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

23.0

330

1829

G01AA10

ATC

clindamycin; vaginal

1.3

23.0

1703

13339

B01AB05

ATC

enoxaparin; parenteral

1.2

23.0

3579

30653

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

22.9

613

4006

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.3

22.9

176

779

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.9

22.9

287

1525

EMB10

NOMESCO Finland

Tonsillectomy

1.6

22.8

529

3342

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

22.8

282

1491

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

22.8

572

3684

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.6

22.7

576

3717

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

22.7

898

6355

P01BA02

ATC

hydroxychloroquine; oral

1.4

22.7

927

6599

R05DA09

ATC

dextromethorphan; oral

2.2

22.6

181

815

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.5

22.5

737

5027

8070/3-C32.0

ICD-O-3

Squamous cell carcinoma, NOS, of glottis

6.6

22.5

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.7

22.5

448

2725

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.9

22.5

295

1590

SPAT1263

SPAT

Sampling

1.2

22.5

4693

41362

A02BA03

ATC

famotidine; systemic

1.8

22.5

369

2130

X15

ICPC

Vaginal symptom/complaint other

1.7

22.4

434

2621

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.6

22.4

598

3906

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

22.3

322

1788

UJC02

NOMESCO Finland

Rigid oesophagoscopy

2.9

22.2

104

362

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

22.2

177

795

M65.3

ICD-10 Finland

Trigger finger

1.6

22.2

539

3444

R75

ICPC

Sinusitis acute/chronic

1.6

22.2

544

3485

R30.0

ICD-10 Finland

Dysuria

1.6

22.2

475

2945

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.0

22.2

231

1152

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.6

22.1

476

2953

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

22.1

3300

28112

RL120, ,

NOMESCO Finland

21.4

22.1

R07

ICPC

Sneezing/nasal congestion

1.5

22.0

679

4575

A60

ICPC

General and Unspecified, Result test/procedure

1.6

22.0

462

2849

1430

FHL

Laryngoscopy (direct)

7.3

22.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.6

22.0

575

3739

TQW40, ,

SPAT

1.4

21.8

1114

8243

R01AX03

ATC

ipratropium bromide; nasal

2.0

21.8

225

1118

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

21.7

741

5097

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

2.6

21.7

128

503

ZY010

NOMESCO Finland

Hospital outpatient

1.6

21.6

504

3190

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.9

21.6

277

1483

H13

ICPC

Plugged feeling ear

1.3

21.6

2116

17182

N28

ICPC

Limited function/disability (N)

2.2

21.6

189

883

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

21.6

637

4254

SPAT1043

SPAT

Audiometry

1.4

21.5

1037

7599

H10

ICD-10 Finland

Conjunctivitis

1.5

21.4

783

5458

SPAT1301

SPAT

No procedures

1.2

21.4

3409

29215

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

21.4

524

3357

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.6

21.3

473

2959

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

1.9

21.3

273

1462

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

2.5

21.3

135

549

H02.3

ICD-10 Finland

Blepharochalasis

1.5

21.3

737

5086

N07CA01

ATC

betahistine; oral

1.5

21.3

762

5293

RD210, ,

NOMESCO Finland

2.2

21.3

187

875

R5599

NOMESCO Finland

Other rehabilitation service

1.8

21.3

296

1627

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

21.2

509

3244

N64.4

ICD-10 Finland

Mastodynia

1.7

21.2

402

2416

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

21.1

2971

25133

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.6

21.1

503

3201

C03CA01

ATC

furosemide; systemic

1.2

21.0

3103

26377

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

3.6

20.9

185

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

2.7

20.9

113

425

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

2.1

20.9

194

927

A01AB10

ATC

natamycin; local oral

1.8

20.9

304

1694

R77

ICPC

Laryngitis/tracheitis acute

4.0

20.8

145

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.8

20.8

285

1559

R31

ICD-10 Finland

Unspecified haematuria

1.4

20.8

977

7130

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

20.7

520

3350

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.6

20.7

508

3255

Z57.3

ICD-10 Finland

Occupational exposure to other air contaminants

3.6

20.7

182

4760A

ICD-9 Finland

Chronic laryngitis and laryngotracheitis, Chronic laryngitis

5.7

20.6

J01CA08

ATC

pivmecillinam; oral

1.2

20.6

4992

44500

R01AC01

ATC

cromoglicic acid; nasal

1.7

20.6

375

2229

A27

ICPC

Fear of other disease NOS

1.6

20.6

549

3586

F16

ICPC

Eyelid symptom/complaint

1.5

20.5

575

3796

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.3

20.5

151

657

XKC03

NOMESCO Finland

Water cystometry

1.8

20.5

322

1836

L18

ICPC

Muscle pain

1.6

20.4

467

2942

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.4

20.4

914

6613

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

20.4

641

4336

G54.0

ICD-10 Finland

Brachial plexus disorders

1.8

20.4

283

1554

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.2

20.4

168

766

S08

ICPC

Skin colour change

1.5

20.4

598

3988

D02AE01

ATC

carbamide; topical

1.5

20.4

655

4453

XQ802

NOMESCO Finland

Epicutan test

1.6

20.3

441

2743

SPAT1059

SPAT

Spirometry at the office

1.6

20.3

515

3325

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

20.3

485

3088

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

3.7

20.3

175

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.1

20.3

198

965

Z31.5

ICD-10 Finland

Genetic counselling

1.5

20.3

572

3783

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.3

20.2

1604

12668

TQW99

NOMESCO Finland

Other minor procedure on skin

1.6

20.2

524

3401

4CJ01, ,

NOMESCO Finland

5.1

20.2

SPAT1336

SPAT

Request for examination

1.7

20.2

369

2196

IGY02

NOMESCO Finland

Psychiatric monitoring contact

1.8

20.1

295

1649

L50.3

ICD-10 Finland

Dermatographic urticaria

2.1

20.1

196

955

SPAT1040

SPAT

Nasolaryngoscopy

4.4

20.0

115

N06AX22

ATC

agomelatine; oral

1.9

20.0

238

1243

EB1VA, ,

NOMESCO Finland

1.3

20.0

1997

16236

G47.8

ICD-10 Finland

Other sleep disorders

2.1

20.0

192

930

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.5

20.0

657

4487

R03BB07

ATC

umeclidinium bromide; inhalant

2.7

20.0

107

401

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

19.9

1021

7557

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.4

19.9

830

5929

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.4

19.9

1004

7412

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

19.9

860

6184

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

2.1

19.9

175

820

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

19.8

479

3058

D22

ICD-10 Finland

Melanocytic naevi

1.5

19.8

585

3907

N02CC05

ATC

almotriptan; oral

1.6

19.8

421

2606

4700A

ICD-9 Finland

Deflected nasal septum[DEFORMATIO SEPTI NASI]

2.4

19.8

140

599

ZXD05

NOMESCO Finland

Urgent procedure

1.2

19.7

3190

27342

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

1.6

19.7

408

2508

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

4.2

19.7

121

D25

ICPC

Abdominal distension

1.9

19.6

228

1182

B35.1

ICD-10 Finland

Tinea unguium

1.5

19.6

715

4982

S01GX08

ATC

ketotifen; ophthalmic

1.6

19.6

477

3051

A09

ICPC

Sweating problem

2.3

19.6

150

664

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.5

19.5

733

5136

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

1.7

19.5

366

2193

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

19.5

241

1276

R81

ICPC

Pneumonia

1.6

19.5

403

2477

R10.2

ICD-10 Finland

Pelvic and perineal pain

1.8

19.5

266

1454

A05

ICPC

Feeling ill

1.5

19.5

578

3864

S01GX05

ATC

lodoxamide; ophthalmic

2.2

19.4

154

692

S01AA01

ATC

chloramphenicol; ophthalmic

1.6

19.4

496

3209

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

19.4

159

724

E000006, ,

ATC

1.5

19.3

712

4971

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

19.3

1065

7977

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

3.2

19.3

235

R03AC19

ATC

olodaterol

3.6

19.3

172

N81.6

ICD-10 Finland

Rectocele

1.4

19.2

765

5418

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.5

19.2

644

4413

C03DA01

ATC

spironolactone; oral

1.3

19.2

1235

9465

M81.0

ICD-10 Finland

Postmenopausal osteoporosis

1.7

19.2

339

1998

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.6

19.2

440

2774

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

19.2

424

2650

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

19.2

632

4318

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

19.2

301

1717

D06AX01

ATC

fusidic acid; topical

1.4

19.1

917

6711

Z02.7

ICD-10 Finland

Issue of medical certificate

1.4

19.1

775

5511

M05BX04

ATC

denosumab; parenteral

1.5

19.1

683

4744

WX723

NOMESCO Finland

CPAP therapy

1.6

19.0

444

2812

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.0

19.0

205

1037

J31.1

ICD-10 Finland

Chronic nasopharyngitis

2.6

19.0

111

435

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.3

19.0

1279

9872

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

1.4

19.0

1025

7652

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

1.8

18.9

283

1591

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

18.9

244

1310

G12.2

ICD-10 Finland

Motor neuron disease

3.5

18.9

179

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

18.9

502

3277

R68.88

ICD-10 Finland

Other specified general symptoms and signs, not elsewhere classified.

2.7

18.8

101

379

TEA00

NOMESCO Finland

Biopsy of lip

2.5

18.8

120

490

M76.6

ICD-10 Finland

Achilles tendinitis

1.5

18.8

530

3505

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

1.8

18.8

270

1500

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.6

18.8

481

3114

N02CC06

ATC

eletriptan; oral

1.7

18.7

378

2309

TGC00

NOMESCO Finland

Bronchial lavation

1.8

18.7

258

1415

H02BX01

ATC

methylprednisolone, combinations; systemic

1.6

18.7

496

3237

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

18.7

1056

7939

K07.65

ICD-10 Finland

Temporomandibular joint-pain-dysfunction syndrome

2.4

18.7

126

528

I84

ICD-10 Finland

Hemorrhoids

1.8

18.6

281

1584

R41.3

ICD-10 Finland

Other amnesia

1.7

18.6

305

1761

R01BA01

ATC

phenylpropanolamine; oral

1.5

18.6

548

3658

WX290, ,

SPAT

1.7

18.6

339

2017

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

1.7

18.6

304

1755

N06AG02

ATC

moclobemide; oral

1.6

18.5

430

2721

M03AX01

ATC

botulinum toxin; parenteral

2.2

18.5

154

706

B37.08

ICD-10 Finland

Other candidal stomatitis

2.5

18.5

116

470

F90.0

ICD-10 Finland

Disturbance of activity and attention

1.7

18.5

303

1750

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

1.9

18.5

227

1200

M01AX01

ATC

nabumetone; oral

1.6

18.5

430

2722

D06BB10

ATC

imiquimod; topical

1.5

18.4

548

3665

G43.8

ICD-10 Finland

Other migraine

2.1

18.4

171

818

JN3AE, ,

SPAT

1.6

18.4

427

2700

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.4

18.4

737

5226

B02AA02

ATC

tranexamic acid; systemic

1.3

18.4

1694

13625

D07XC01

ATC

betamethasone; topical

1.3

18.4

1204

9251

H91.1

ICD-10 Finland

Presbycusis

1.5

18.4

641

4429

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

18.3

389

2407

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.4

18.3

127

539

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.4

18.3

917

6762

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

18.3

1659

13320

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

18.3

1249

9657

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

18.2

643

4452

K85

ICPC

Elevated blood pressure

1.3

18.2

1847

15029

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.1

18.2

162

763

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

1.7

18.2

342

2052

G03FA01

ATC

norethisterone and estrogen; systemic

1.3

18.2

1544

12293

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

1.5

18.2

502

3305

K03.19

ICD-10 Finland

Abrasion of the teeth UNS

2.0

18.2

198

1005

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.5

18.1

493

3234

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

18.1

310

1813

L60.0

ICD-10 Finland

Ingrowing nail

1.5

18.1

499

3284

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.6

18.1

404

2533

4239

FHL

Other measure in this category

3.5

18.0

180

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.7

17.9

355

2160

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.4

17.8

116

478

H10.4

ICD-10 Finland

Chronic conjunctivitis

2.4

17.8

116

478

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

2.2

17.8

151

697

G03DB01

ATC

dydrogesterone; oral

1.3

17.8

1429

11290

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.2

17.8

143

646

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.4

17.8

880

6473

P29

ICPC

Psychological sympt/compl other

1.4

17.8

724

5149

SXC05

NOMESCO Finland

Other oral or dental procedure

1.4

17.8

671

4707

N06AX12

ATC

bupropion; oral

1.4

17.8

694

4900

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

17.7

784

5660

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

1.8

17.7

266

1499

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.3

17.6

1111

8493

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

17.5

315

1867

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

17.5

620

4296

D10AX03

ATC

azelaic acid; topical

1.4

17.5

664

4662

F03

ICPC

Eye discharge

1.4

17.5

725

5174

XJC00

NOMESCO Finland

Oesophageal manometry

3.6

17.5

155

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

17.5

546

3690

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.5

17.5

586

4018

D80.9

ICD-10 Finland

Immunodeficiency with predominantly antibody defects, unspecified

5.2

17.4

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

17.4

736

5270

N94.1

ICD-10 Finland

Dyspareunia

2.2

17.4

137

614

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

17.4

415

2644

F32.1

ICD-10 Finland

Moderate depressive episode

1.5

17.4

590

4056

G20

ICD-10 Finland

Parkinson disease

1.7

17.4

303

1782

K29

ICPC

Cardiovascular sympt/complt other

1.6

17.3

452

2939

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

17.3

1793

14626

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

4.8

17.3

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

17.2

474

3118

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

2.3

17.2

132

585

M15

ICD-10 Finland

Polyarthrosis

1.5

17.2

562

3832

Z58.8

ICD-10 Finland

Other problems related to physical environment

5.2

17.2

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

2.2

17.1

136

612

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

17.1

3312

28810

WZC30

NOMESCO Finland

Teaching

1.3

17.1

1780

14521

W10

ICD-10 Finland

Fall on and from stairs and steps

1.5

17.1

535

3618

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

1.9

17.1

206

1083

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.6

17.1

421

2702

N03AX11

ATC

topiramate; oral

1.8

17.0

255

1435

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

17.0

862

6366

WX780

NOMESCO Finland

Remote monitoring CPAP

1.6

17.0

441

2865

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.7

16.9

332

2014

G04CB02

ATC

dutasteride; oral

1.5

16.9

603

4183

F44.4

ICD-10 Finland

Dissociative motor disorders

6.9

16.9

J02AB02

ATC

ketoconazole; oral

1.7

16.9

286

1667

F43.29

ICD-10 Finland

Adaptation disorder UNS

1.8

16.9

234

1286

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.7

16.9

328

1985

A02BX02

ATC

sucralfate; oral

1.6

16.9

373

2332

L88

ICPC

Rheumatoid/seropositive arthritis

1.5

16.9

459

3013

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

16.8

417

2679

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.6

16.8

357

2210

N41.1

ICD-10 Finland

Chronic prostatitis

2.0

16.8

189

970

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.5

16.8

527

3564

J01MA01

ATC

ofloxacin; systemic

1.4

16.8

775

5634

M01AH03

ATC

valdecoxib; oral

1.5

16.8

613

4272

H81.3

ICD-10 Finland

Other peripheral vertigo

1.7

16.8

305

1814

F34.1

ICD-10 Finland

Dysthymia

1.6

16.7

358

2221

AA1BG, ,

SPAT

1.9

16.7

222

1204

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.4

16.7

746

5395

D02AX

ATC

Other emollients and protectives

1.7

16.7

305

1817

7844X

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[APHONIA SEU DYSPHONIA ALIA SEU NUD]

+∞

16.7

R30.1

ICD-10 Finland

Vesical tenesmus

1.8

16.6

241

1343

SPAT1057

SPAT

Peak expiratory flow measurement

1.8

16.6

230

1264

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.4

16.6

662

4691

M43.1

ICD-10 Finland

Spondylolisthesis

1.6

16.6

427

2768

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.4

16.6

767

5579

SPAT1097

SPAT

Recording of ECG

1.3

16.6

1469

11753

A07EC01

ATC

sulfasalazine; oral, rectal

1.4

16.5

801

5873

L10

ICPC

Elbow symptom/complaint

1.5

16.5

566

3898

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

16.5

2441

20684

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

2.6

16.5

347

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

1.8

16.5

253

1435

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

16.4

296

1756

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.3

16.4

1243

9740

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

1.8

16.4

226

1240

NH3AA, ,

SPAT

1.5

16.4

581

4026

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.5

16.4

103

418

N06BA04

ATC

methylphenidate; oral

1.7

16.4

271

1571

G47.9

ICD-10 Finland

Sleep disorder, unspecified

1.7

16.3

303

1812

H26.4

ICD-10 Finland

After-cataract

1.3

16.3

1037

7929

N62

ICD-10 Finland

Hypertrophy of breast

1.5

16.3

455

3002

G04BD09

ATC

trospium; oral

1.8

16.3

252

1432

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

16.3

3173

27596

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

16.3

254

1448

C01BC04

ATC

flecainide; systemic

1.6

16.3

339

2090

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.3

16.3

1576

12746

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.5

16.2

574

3979

NH1AA, ,

SPAT

1.6

16.2

333

2046

R03CC02

ATC

salbutamol; systemic

1.6

16.2

410

2649

RK110, ,

NOMESCO Finland

2.7

16.2

322

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.4

16.2

651

4623

S03

ICPC

Warts

1.9

16.1

188

978

R68.2

ICD-10 Finland

Dry mouth, unspecified

2.5

16.1

100

404

J02

ICD-10 Finland

Acute pharyngitis

1.6

16.1

331

2034

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.3

16.1

1167

9095

M54.3

ICD-10 Finland

Sciatica

1.4

16.1

635

4494

M19.8

ICD-10 Finland

Other specified arthrosis

1.5

16.0

434

2846

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

1.7

16.0

273

1596

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.2

16.0

2918

25218

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.6

16.0

379

2411

W19

ICD-10 Finland

Unspecified fall

1.3

16.0

978

7437

OAB93, ,

SPAT

1.4

15.9

683

4903

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.3

15.9

954

7231

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

15.9

2025

16889

R06.4

ICD-10 Finland

Hyperventilation

2.0

15.8

162

805

N89

ICPC

Migraine

1.6

15.8

344

2145

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

15.8

1195

9366

J32.4

ICD-10 Finland

Chronic pansinusitis

2.0

15.8

156

766

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

15.7

513

3498

K05.1

ICD-10 Finland

Chronic gingivitis

1.4

15.7

689

4965

SCA02

NOMESCO Finland

Preventive oral health care

1.3

15.7

986

7525

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

2.2

15.7

128

583

SPAT1312

SPAT

General health counselling

1.2

15.7

3357

29426

ACC51

NOMESCO Finland

Release of median nerve

1.4

15.7

812

6019

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.5

15.7

415

2709

B01AF02

ATC

apixaban; oral

1.3

15.6

1348

10742

A62

ICPC

General and Unspecified, Administrative procedure

1.8

15.6

246

1406

SPAT1283

SPAT

Restricted health certificate

1.3

15.6

1634

13329

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

1.9

15.6

207

1124

K07.61

ICD-10 Finland

Cracking jaw joint

1.8

15.5

218

1204

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

1.7

15.5

282

1678

ZXD35

NOMESCO Finland

Usual procedure

1.7

15.5

305

1853

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

3.8

15.5

121

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.5

15.5

530

3650

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

15.5

394

2549

UGB02

NOMESCO Finland

Tracheoscopy

4.8

15.4

SPAT1310

SPAT

Counselling related to known health issue

1.2

15.4

3361

29504

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

1.7

15.3

297

1799

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.6

15.3

396

2573

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.8

15.2

242

1387

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

15.2

765

5642

S20.2

ICD-10 Finland

Contusion of thorax

1.5

15.2

515

3539

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

15.2

694

5037

M70.7

ICD-10 Finland

Other bursitis of hip

1.7

15.2

283

1695

R08

ICPC

Nose symptom/complaint other

1.6

15.2

359

2283

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.0

15.2

155

770

XKD03

NOMESCO Finland

Urethral pressure profilometry

1.8

15.2

234

1330

OAA65, ,

SPAT

1.2

15.2

1854

15388

K07

ICPC

Swollen ankles/oedema

1.5

15.2

487

3312

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

1.9

15.1

174

901

J38

ICD-10 Finland

Diseases of vocal cords and larynx, not elsewhere classified

13.0

15.1

G57.6

ICD-10 Finland

Lesion of plantar nerve

1.8

15.1

233

1324

D04

ICPC

Rectal/anal pain

2.0

15.1

163

826

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.5

15.1

506

3471

G50.0

ICD-10 Finland

Trigeminal neuralgia

1.9

15.1

193

1036

K20

ICD-10 Finland

Oesophagitis

1.9

15.1

172

889

P76

ICPC

Depressive disorder

1.4

15.0

656

4726

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

2.6

15.0

323

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

15.0

284

1709

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.5

15.0

451

3026

G25.2

ICD-10 Finland

Other specified forms of tremor

2.7

15.0

289

F05

ICPC

Visual disturbance other

1.6

15.0

338

2126

WW200

NOMESCO Finland

Immunization

1.7

15.0

260

1529

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.3

14.9

116

518

RS221, ,

NOMESCO Finland

2.1

14.9

137

654

L29.9

ICD-10 Finland

Pruritus, unspecified

1.7

14.9

297

1811

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

2.2

14.9

129

602

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

14.9

4278

38383

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.4

14.9

658

4749

K11.2

ICD-10 Finland

Sialoadenitis

1.6

14.9

353

2248

C10AA03

ATC

pravastatin; oral

1.4

14.8

682

4956

B01AC04

ATC

clopidogrel; oral

1.3

14.8

1522

12384

G45.3

ICD-10 Finland

Amaurosis fugax

1.9

14.8

196

1063

N99

ICPC

Neurological disease other

2.1

14.8

130

610

S01XA18

ATC

ciclosporin; ophthalmic

2.4

14.8

402

R06AX18

ATC

acrivastine; oral

1.7

14.8

281

1692

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.6

14.8

323

2016

D09

ICPC

Nausea

1.5

14.8

446

2995

D18

ICPC

Change in faeces/bowel movements

1.7

14.8

275

1648

D93

ICPC

Irritable bowel syndrome

2.0

14.8

147

724

F60.5

ICD-10 Finland

Anankastic personality disorder

2.2

14.7

116

521

R07.2

ICD-10 Finland

Precordial pain

1.8

14.7

210

1166

Z51.6

ICD-10 Finland

Desensitization to allergens

2.3

14.7

109

477

R5120

NOMESCO Finland

Preparation of an aid

1.7

14.7

283

1710

K03.66

ICD-10 Finland

Tooth plaque

1.4

14.7

786

5854

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.4

14.7

744

5494

RK120, ,

NOMESCO Finland

3.8

14.7

112

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

14.7

2363

20161

Y06

ICPC

Prostate symptom/complaint

1.7

14.7

248

1447

H60

ICD-10 Finland

Otitis externa

1.5

14.7

523

3630

N06AX03

ATC

mianserin; oral

1.5

14.7

465

3154

K59.01

ICD-10 Finland

Constipation outlet obstruction type

2.1

14.7

143

699

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

2.0

14.6

166

856

I20.09

ICD-10 Finland

Unstable angina

1.5

14.6

498

3428

K07.68

ICD-10 Finland

Other disorders of the jaw joint

2.5

14.6

375

F80.1

ICD-10 Finland

Expressive language disorder

2.7

14.6

299

R14

ICD-10 Finland

Flatulence and related conditions

2.2

14.6

114

511

M05BA07

ATC

risedronic acid; oral

1.6

14.6

299

1838

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

1.8

14.5

213

1193

D01AC03

ATC

econazole; topical

1.4

14.5

552

3880

EB1WA, ,

NOMESCO Finland

2.8

14.5

255

XJH00

NOMESCO Finland

Transanal ultrasonography

1.5

14.5

480

3286

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.5

14.5

470

3205

OAA80, ,

SPAT

0.7

14.4

422

6204

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.5

14.4

478

3271

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

14.4

186

1001

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.2

14.4

114

513

B07.9

ICD-10 Finland

Verruca simplex

1.6

14.4

359

2312

S02

ICPC

Pruritus

1.6

14.4

361

2328

J01.1

ICD-10 Finland

Acute frontal sinusitis

1.9

14.4

168

875

B02.9

ICD-10 Finland

Zoster without complication

1.4

14.4

713

5249

AN1

Coronary angiography

1.3

14.4

964

7429

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

1.9

14.4

186

1003

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

1.5

14.3

398

2626

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

1.8

14.3

201

1111

-60

ICPC

Result test/procedure

1.4

14.3

561

3964

S92.5

ICD-10 Finland

Fracture of other toe

1.7

14.3

282

1715

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.5

14.3

420

2804

I95.1

ICD-10 Finland

Orthostatic hypotension

1.6

14.3

358

2308

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

2.1

14.3

138

672

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.8

14.3

222

1265

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.4

14.3

650

4716

XX7CT

NOMESCO Finland

Radioiodine therapy of thydoid tissue

2.2

14.3

118

541

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

14.3

414

2757

R05DB05

ATC

pentoxyverine; oral, rectal

1.6

14.3

342

2183

L71.8

ICD-10 Finland

Other rosacea

1.9

14.2

189

1027

R33

ICD-10 Finland

Retention of urine

1.4

14.2

681

4983

U04

ICPC

Incontinence urine

1.4

14.2

600

4297

NF1AA

NOMESCO Finland

Hip X-ray examination

1.3

14.2

931

7149

HA1RA, ,

SPAT

1.5

14.2

512

3562

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

1.8

14.2

204

1136

C09CA01

ATC

losartan; oral

1.2

14.1

2726

23641

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

14.1

803

6039

NA1BG, ,

SPAT

1.8

14.1

189

1030

J33.8

ICD-10 Finland

Other polyp of sinus

1.8

14.1

192

1052

B01AB04

ATC

dalteparin; parenteral

1.5

14.1

511

3560

WX203

NOMESCO Finland

Infraclavicular plexus blockade

1.7

14.1

241

1412

TKC20

NOMESCO Finland

Catheterisation of bladder

1.4

14.1

613

4415

WZC00, ,

SPAT

1.2

14.1

1588

13060

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

2.6

14.1

299

G03CA04

ATC

estriol; systemic, vaginal

1.4

14.0

647

4705

L04AX01

ATC

azathioprine; systemic

1.5

14.0

401

2663

N02CC07

ATC

frovatriptan; oral

1.5

14.0

400

2655

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

14.0

412

2754

49300

ICD-8 Finland

Asthma, bronchiale

1.8

13.9

220

1262

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

13.8

1227

9808

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

6.0

13.8

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.5

13.8

461

3160

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.5

13.8

489

3391

K02

ICPC

Pressure/tightness of heart

1.7

13.8

233

1360

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

13.8

885

6775

RL310, ,

NOMESCO Finland

53.4

13.8

J33.0

ICD-10 Finland

Polyp of nasal cavity

1.7

13.8

266

1610

X57

ICD-10 Finland

Unspecified privation

1.7

13.8

222

1279

N02AA05

ATC

oxycodone; systemic

1.2

13.8

1842

15424

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.7

13.7

224

1295

N06AA12

ATC

doxepin; systemic

1.5

13.7

486

3370

SBA10

NOMESCO Finland

Measurement of salivary flow rate

2.2

13.7

111

505

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

13.7

703

5203

G43

ICD-10 Finland

Migraine

1.4

13.7

517

3629

-, ,

ICD-10 Finland

1.8

13.7

215

1230

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

2.1

13.7

125

597

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

1.9

13.7

176

948

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

2.1

13.6

120

565

7844A

ICD-9 Finland

Symptoms involving head and neck, Voice disturbance[DYSPHONIA HYPERFUNCTIONALIS]

+∞

13.5

M20.2

ICD-10 Finland

Hallux rigidus

1.6

13.5

318

2024

N87

ICPC

Parkinsonism

2.0

13.5

150

770

R97

ICPC

Allergic rhinitis

1.8

13.5

189

1046

B977, D141,

ICD-10 Finland

140.2

13.4

P74

ICPC

Anxiety disorder/anxiety state

1.5

13.4

420

2842

SPA41

NOMESCO Finland

Precision impression for fixed dental prosthesis

1.9

13.4

175

946

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

13.4

1149

9144

R28

ICPC

Limited function/disability (R)

2.0

13.4

132

648

G04BD07

ATC

tolterodine; oral

1.5

13.4

443

3033

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

1.7

13.4

241

1433

L84

ICD-10 Finland

Corns and callosities

1.6

13.4

344

2233

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

13.4

773

5829

P25

ICPC

Phase of life problem adult

1.5

13.4

423

2870

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

1.9

13.3

158

828

SPAT1254

SPAT

Administration of medicine

1.3

13.3

1420

11602

H53.2

ICD-10 Finland

Diplopia

1.6

13.3

313

1991

R61

ICD-10 Finland

Hyperhidrosis

2.2

13.3

111

512

C07AB02

ATC

metoprolol; systemic

1.2

13.3

1939

16376

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

1.9

13.3

152

788

SPAT1240

SPAT

Therapeutic discussion

1.3

13.2

969

7556

K44

ICD-10 Finland

Diaphragmatic hernia

2.3

13.2

436

-1, ,

ICD-10 Finland

1.5

13.2

453

3122

K03.0

ICD-10 Finland

Excessive attrition of teeth

1.6

13.2

291

1821

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.0

13.2

140

706

PD5BD

NOMESCO Finland

Extensive CT of aorta

1.9

13.2

159

838

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

2.4

13.2

381

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

13.2

1647

13691

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

2.0

13.1

137

687

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

2.4

13.1

345

M09AX01

ATC

hyaluronic acid; parenteral

1.5

13.1

438

3004

R19.4

ICD-10 Finland

Change in bowel habit

1.6

13.1

311

1982

LEG10

NOMESCO Finland

Vaginal urethrocystopexy

1.7

13.1

249

1502

E66.8

ICD-10 Finland

Other obesity

1.4

13.1

566

4072

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

2.6

13.0

293

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

2.4

13.0

377

D64.9

ICD-10 Finland

Anaemia, unspecified

1.3

13.0

1051

8302

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.5

13.0

399

2691

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.5

13.0

443

3051

L01BA01

ATC

methotrexate; systemic

1.5

13.0

359

2368

S15

ICPC

Foreign body in skin

1.4

13.0

658

4861

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.9

13.0

147

759

K13.78

ICD-10 Finland

Other change in the oral mucosa

1.6

13.0

273

1690

B01AA03

ATC

warfarin; systemic

1.2

13.0

1681

14023

E000007, ,

ATC

1.4

13.0

515

3650

S01BA01

ATC

dexamethasone; ophthalmic

1.6

13.0

323

2082

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

1.9

12.9

156

823

JAH01

NOMESCO Finland

Laparoscopy

1.4

12.9

476

3327

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.8

12.9

203

1162

M67.4

ICD-10 Finland

Ganglion

1.4

12.9

709

5305

BA1AE, ,

SPAT

2.0

12.9

137

692

N03AF01

ATC

carbamazepine; oral, rectal

1.5

12.9

451

3122

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.0

12.9

141

720

J01DC04

ATC

cefaclor; oral

2.1

12.9

120

578

SGA05

NOMESCO Finland

Opening and preparing the root canals, extremely complicated And time consuming

1.4

12.8

564

4069

D01AE15

ATC

terbinafine; topical

1.4

12.8

651

4812

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.3

12.8

821

6287

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

2.8

12.8

233

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

12.8

1329

10825

D29

ICPC

Digestive symptom/complaint other

1.7

12.7

249

1513

N06AB08

ATC

fluvoxamine; oral

1.7

12.7

249

1513

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

1.7

12.7

206

1189

A07EA06

ATC

budesonide; oral, local oral

1.5

12.7

360

2386

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

3.5

12.7

124

H03BB01

ATC

carbimazole; oral

1.5

12.7

423

2899

R01AC02

ATC

levocabastine; nasal

1.6

12.7

265

1637

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.5

12.7

371

2476

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

1.6

12.7

318

2052

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.4

12.7

688

5138

J01.4

ICD-10 Finland

Acute pansinusitis

2.5

12.7

315

DM1AI, ,

SPAT

2.4

12.7

339

R06AX11

ATC

astemizole; oral

1.6

12.7

252

1539

C05AA01

ATC

hydrocortisone; rectal, topical

1.4

12.7

477

3349

L04AX03

ATC

methotrexate; systemic

1.3

12.6

993

7817

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

2.1

12.6

121

589

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

1.7

12.6

221

1305

K59.8

ICD-10 Finland

Other specified functional intestinal disorders

2.6

12.6

269

R43

ICPC

Respiratory, Other diagnostic procedure

2.4

12.6

340

EMAK, ,

NOMESCO Finland

1.5

12.6

339

2224

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

1.9

12.6

153

810

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.6

12.6

290

1837

Z05

ICPC

Work problem

1.6

12.5

319

2066

H81

ICPC

Excessive ear wax

1.2

12.5

1772

14909

K10.3

ICD-10 Finland

Alveolitis of jaws

1.5

12.5

452

3147

D01AC02

ATC

miconazole; topical

1.4

12.5

675

5035

D01AC07

ATC

tioconazole; topical

1.6

12.5

321

2083

L09

ICPC

Arm symptom/complaint

1.4

12.5

505

3590

I73.0

ICD-10 Finland

Raynaud syndrome

1.8

12.5

178

990

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

4.1

12.5

N76.1

ICD-10 Finland

Subacute and chronic vaginitis

1.7

12.4

240

1454

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

12.4

395

2683

C08CA05

ATC

nifedipine; systemic

1.4

12.4

549

3965

X72

ICPC

Genital candidiasis female

2.1

12.4

111

526

NG1BG, ,

SPAT

1.5

12.4

375

2521

J06BA01

ATC

immunoglobulins, normal human, for extravascular adm.; systemic

4.2

12.4

M89.0

ICD-10 Finland

Algoneurodystrophy

2.3

12.4

423

G03DA02

ATC

medroxyprogesterone; systemic

1.3

12.4

931

7284

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

3.2

12.4

146

4364

FHL

Pharyngeal tongue plastic

13.1

12.4

IGY99

NOMESCO Finland

Other psychiatric treatment contact

1.8

12.4

175

971

R03DX05

ATC

omalizumab; parenteral

5.0

12.4

R06

ICD-10 Finland

Abnormalities of breathing

2.1

12.4

108

507

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

1.8

12.3

188

1067

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

12.3

1919

16296

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.3

12.3

399

EBA05, ,

SPAT

1.9

12.3

160

865

G01AF02

ATC

clotrimazole; vaginal

1.5

12.3

366

2454

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.0

12.3

131

663

EB1MA

NOMESCO Finland

Cephalometry with X-ray

1.8

12.3

171

945

C10AA01

ATC

simvastatin; oral

1.2

12.3

4237

38406

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.6

12.3

256

1583

L84

ICPC

Back syndrome without radiat pain

1.4

12.2

484

3428

Angiography of the heart and coronary arteries

1.4

12.2

478

3378

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

12.2

401

2741

N02CD06

ATC

rimegepant; oral

2.6

12.2

279

ZX120

NOMESCO Finland

Intravenous

1.3

12.2

907

7087

M77.0

ICD-10 Finland

Medial epicondylitis

1.6

12.2

262

1632

S70.0

ICD-10 Finland

Contusion of hip

1.5

12.1

367

2468

N02AJ13

ATC

tramadol and paracetamol; systemic

1.7

12.1

228

1373

U09

ICD-10 Finland

Post COVID-19 condition

2.2

12.1

434

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.5

12.1

346

2302

S83.2

ICD-10 Finland

Tear of meniscus, current

1.4

12.0

640

4766

N02CX04, ,

ATC

1.7

12.0

209

1232

A69

ICPC

General and Unspecified, Other reason for encounter NEC

1.6

12.0

270

1700

K13.29

ICD-10 Finland

Indefinite leukoplakia

2.1

12.0

113

547

K07.4

ICD-10 Finland

Malocclusion, unspecified

1.8

12.0

160

873

B35.3

ICD-10 Finland

Tinea pedis

1.4

11.9

443

3102

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

1.5

11.9

400

2747

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

11.9

1936

16504

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

2.5

11.9

277

ZA1.0

ICD-10 Finland

Shoulder region

1.7

11.9

234

1426

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

2.0

11.9

125

630

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.6

11.9

306

1989

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

11.9

1304

10684

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

1930

8103

2.62

292.87

1.6

1.3

150.52

233.09

u/ml

3.75

1815

7508

(3013115) Eosinophils [#/volume] in Blood

8540

64139

1.94

271.95

7.0

6.6

0.19

e9/l

0.81

7492

56002

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

10840

89196

2.21

258.94

5.6

4.5

11.12

12.36

mm/h

20.00

10309

83726

(3001604) Monocytes [#/volume] in Blood

8288

62153

1.90

258.76

6.8

6.4

0.56

0.58

e9/l

9.52

7142

53358

(3006315) Basophils [#/volume] in Blood

8298

62331

1.89

256.78

6.9

6.4

0.04

e9/l

0.68

7146

53486

(3019198) Lymphocytes [#/volume] in Blood

8378

63491

1.88

247.80

6.9

6.4

1.86

1.92

e9/l

3.02

7407

55838

(3013650) Neutrophils [#/volume] in Blood by Automated count

8882

69588

1.85

224.23

9.5

9.8

3.96

4.10

e9/l

6.64

7735

60347

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11058

93779

2.10

211.86

6.0

4.6

14.79

14.75

pmol/l

1.07

10452

86654

(3019069) Monocytes/Leukocytes in Blood

7578

57283

1.76

208.51

7.1

6.7

8.75

8.78

0.50

7151

53711

(3006504) Eosinophils/Leukocytes in Blood

7557

57151

1.75

206.86

7.0

6.6

2.87

2.84

0.56

7119

53546

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7361

55325

1.75

205.29

7.0

6.5

1.21

mmol/l

0.25

6933

51224

(3018010) Neutrophils/Leukocytes in Blood

7577

57433

1.75

204.85

6.9

6.4

56.83

57.29

3.04

7253

54848

(3022096) Basophils/Leukocytes in Blood

7545

57125

1.75

204.79

7.1

6.7

0.70

0.69

1.75

7106

53468

(3002030) Lymphocytes/Leukocytes in Blood

7678

58541

1.74

202.03

7.0

6.6

28.18

27.90

1.54

7302

55437

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8023

61978

1.75

201.03

7.6

7.2

1.22

mmol/l

0.09

7105

53606

(3018418) pH of Serum or Plasma

5405

37539

1.74

197.20

4.5

4.2

7.40

0.28

3845

26802

(40768797) Stomach Pathology biopsy report

2983

17383

1.93

193.54

1.3

1.2

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1905

9491

2.18

190.29

1.7

1.5

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4335

28744

1.76

182.79

1.4

1.3

1.53

1.67

u/ml

0.28

1101

7869

(3007164) IgA [Mass/volume] in Serum or Plasma

3843

24809

1.77

176.59

1.6

1.5

2.28

2.38

g/l

2.27

2287

15263

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

10739

92041

1.90

171.86

9.1

8.4

76.46

79.05

u/l

7.90

10314

87581

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

12134

109008

2.40

166.04

7.5

5.6

1.81

1.90

mu/l

14.92

11514

101453

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7555

59023

1.65

165.98

3.6

3.2

110.73

118.04

ug/l

1.15

7134

55195

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4066

27202

1.72

161.71

1.9

1.7

0.96

1.20

mg/l

7.29

3166

21170

(3024561) Albumin [Mass/volume] in Serum or Plasma

7130

55282

1.63

158.01

5.1

5.0

36.23

35.69

g/l

14.97

6693

51857

(3048689) Calprotectin [Mass/mass] in Stool

2708

16198

1.85

157.74

2.2

2.4

109.50

129.49

ug/g

2.72

2174

12804

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7005

54095

1.63

157.64

2.4

2.1

98.56

97.02

pmol/l

1.86

3581

28370

(3037467) Urinalysis macro (dipstick) panel - Urine

9739

81928

1.72

155.06

5.6

4.7

1.24

2.31

0.99

124

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5165

37263

1.63

151.08

2.4

2.2

171.89

197.96

u/l

1.48

4903

35187

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

12507

114770

2.71

148.15

20.8

16.2

21.88

23.78

mg/l

9.42

10714

94843

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

7250

57073

1.60

145.67

2.8

2.5

80.24

1656.48

nmol/l

0.50

6651

51951

(3031040) Bacteria [#/volume] in Urine by Automated count

9427

79175

1.67

144.70

5.9

4.8

961.09

2057.12

e6/l

1.70

1070

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3707

24831

1.69

143.24

3.0

2.44

2.45

mmol/l

4.73

3298

22321

(3018095) Leukocytes [#/volume] in Urine

6000

45412

1.59

140.56

4.9

4.0

56.38

103.49

e6/l

10.62

4224

31815

(3015377) Calcium [Moles/volume] in Serum or Plasma

5739

43310

1.58

133.94

3.5

3.6

2.35

2.36

mmol/l

1.75

5241

39454

(3030467) Casts [#/volume] in Urine by Automated count

4717

34196

1.59

129.70

3.9

3.3

0.30

0.42

e6/l

4.21

3437

25019

(3033658) Prothrombin time (PT) actual/Normal

4337

30832

1.61

129.46

4.5

4.1

91.16

90.85

0.35

4243

30124

(36304419) Bacteria [Presence] in Urine

4514

32514

1.59

126.87

3.8

3.2

67.34

125.42

estimate

0.20

133

(3044889) 12 lead EKG panel

9599

82042

1.62

126.39

4.8

4.0

5942.47

2059.65

0.27

161

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7878

64371

1.56

125.60

6.3

6.6

10.92

11.25

umol/l

1.72

7506

61375

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3426

23144

1.65

124.96

4.6

3.8

212.95

435.71

ng/l

3.22

2586

17721

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3558

24272

1.64

124.79

1.4

1.3

27.85

32.64

iu/ml

1.07

1076

7459

(3002582) Erythrocytes [#/volume] in Urine

5274

39602

1.55

122.26

4.0

3.4

31.98

81.47

e6/l

7.50

4010

30175

(3000494) Fungus identified in Specimen by Culture

2378

14901

1.73

113.78

1.6

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

341

899

3.87

112.33

1.6

1.3

1.90

1.77

u/ml

0.08

216

520

(40758558) Short blood count panel - Blood

4932

37010

1.53

111.68

6.5

6.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3161

21446

1.62

111.10

3.5

3.0

0.85

1.30

e6/l

2.44

1657

11424

(40768804) Tissue Pathology biopsy report

6354

50357

1.50

110.56

2.4

2.2

—

(3021589) Normoblasts [#/volume] in Blood

6677

53461

1.50

110.55

12.1

11.6

0.00

e9/l

0.78

5300

43469

(3013826) Glucose [Moles/volume] in Serum or Plasma

8356

70177

1.52

109.24

5.7

5.0

6.46

6.67

mmol/l

20.97

8031

66496

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1509

8393

1.90

106.82

3.9

3.5

4.44

4.46

pmol/l

0.42

1359

7538

(3037522) Nuclear Ab [Titer] in Serum

2744

18126

1.65

106.73

1.5

1.4

519.44

516.12

titre

0.03

567

4056

(3021960) Folate [Moles/volume] in Serum or Plasma

4701

35209

1.52

105.84

1.8

1.7

21.50

20.37

nmol/l

4.12

4139

29935

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3248

22518

1.59

103.01

1.4

1.3

9.83

11.40

u/ml

0.43

1202

8915

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2883

19448

1.62

102.47

3.7

3.1

2.47

3.04

e6/l

2.06

1356

9405

(3011397) Hemoglobin [Presence] in Urine by Test strip

4064

29751

1.53

100.59

4.3

3.9

0.47

0.34

0.17

305

(3009261) Glucose [Presence] in Urine by Test strip

7829

65435

1.48

100.22

4.6

4.0

0.00

0.27

estimate

1.34

1439

13015

(3019550) Sodium [Moles/volume] in Serum or Plasma

12492

116957

2.27

99.47

23.2

18.8

139.78

139.69

mmol/l

4.50

12348

114795

(3021601) Nitrite [Presence] in Urine by Test strip

7695

64201

1.48

98.59

4.5

4.0

0.00

estimate

0.05

1487

13344

(3035350) Ketones [Presence] in Urine by Test strip

7765

64959

1.47

97.70

4.6

4.0

1.66

4.08

estimate

1.12

1512

13713

(3014051) Protein [Presence] in Urine by Test strip

4606

34786

1.50

97.48

3.3

3.0

0.18

0.06

0.39

792

(3023103) Potassium [Moles/volume] in Serum or Plasma

12496

117175

2.25

96.30

23.6

19.0

3.95

3.96

mmol/l

10.95

12340

114820

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1903

11765

1.72

93.84

2.7

2.5

55.16

42.79

u/l

0.29

1611

9936

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4685

35834

1.48

91.53

3.3

3.1

999.16

1337.32

ng/l

8.85

4045

30956

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2146

13823

1.66

90.39

2.0

1.9

—

(36660697) Celiac disease serology panel - Serum

1668

10041

1.76

90.17

1.2

—

(3015736) pH of Urine

6364

51738

1.44

89.59

4.0

3.5

6.25

6.23

0.76

3280

28882

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4312

32585

1.48

88.89

2.5

2.4

2.61

2.82

mg/l

7.10

3738

28298

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2246

14768

1.63

86.81

2.0

1.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1886

11871

1.69

86.43

2.4

2.3

365.00

379.31

nmol/l

2.53

1747

11023

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

11962

111038

1.83

86.40

5.9

5.2

5.82

5.91

mmol/l

10.99

11198

102461

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2869

20008

1.55

86.22

2.1

1.9

—

(3023419) Bacteria identified in Sputum by Culture

422

1513

2.85

84.40

3.1

2.6

—

(3000850) Epithelial cells [#/volume] in Urine

3701

27449

1.48

82.42

2.9

2.7

4.89

6.01

e6/l

6.30

3343

24976

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2922

20637

1.53

82.34

3.2

3.4

0.82

mmol/l

1.17

2744

19463

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

10614

95946

1.54

80.90

24.7

19.8

13.59

13.64

4.19

10512

94741

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1120

6214

1.88

78.73

1.2

1.1

20.37

2.02

u/ml

0.45

(3005719) IgG [Mass/volume] in Serum or Plasma

1557

9539

1.72

78.31

2.8

2.9

10.04

10.52

g/l

4.16

1439

8831

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

333

1091

3.11

78.20

3.9

3.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5122

40784

1.42

76.63

3.2

3.3

30.67

33.96

u/l

3.50

4840

38484

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

12685

120739

2.30

76.30

14.7

12.4

25.22

25.38

u/l

0.44

12426

117410

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

675

3173

2.19

75.31

1.2

3.85

3.99

0.13

432

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9017

79331

1.43

75.06

3.6

3.3

46.58

46.27

u/l

0.10

8487

74573

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

11694

108619

1.67

74.23

6.9

6.4

38.58

39.14

mmol/mol

12.51

11088

101835

(3020564) Creatinine [Moles/volume] in Serum or Plasma

12735

121533

2.36

74.04

25.9

21.0

75.80

75.55

umol/l

0.40

12650

120214

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

11865

110645

1.72

74.00

19.3

15.7

80.77

80.65

ml/min/173m2

0.29

11188

102530

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1422

8664

1.72

72.64

2.5

2.4

22.76

21.88

au/ml

0.14

138

966

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4909

39145

1.40

71.26

2.9

2.7

61.35

62.49

u/l

0.17

4563

36290

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2132

14466

1.57

70.63

2.6

2.7

7.02

8.27

umol/l

1.79

1843

12554

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1317

8010

1.72

67.44

1.3

47.09

53.21

au/ml

0.40

547

(3032080) INR in Blood by Coagulation assay

6532

55011

1.37

66.36

16.2

14.5

1.25

1.24

inr

0.37

5388

45794

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2530

18088

1.49

65.08

2.1

29.59

29.57

0.05

2456

17598

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

6040

50373

1.37

64.56

2.0

1.9

1.30

1.34

mmol/l

4.57

5170

42277

(3013139) Helicobacter pylori Ag [Presence] in Stool

1405

8816

1.66

63.81

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

321

1164

2.80

62.84

6.3

5.3

57.34

109.86

u/ml

1.16

120

379

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

740

3854

1.97

62.51

1.9

1.8

0.23

g/l

0.86

705

3660

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

12200

115412

1.75

62.26

6.6

5.8

2.68

2.73

mmol/l

8.80

11502

107718

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

531

2446

2.22

62.17

1.2

1.1

1.02

2.06

u/ml

2.87

300

1275

(3015171) Extractable nuclear Ab [Units/volume] in Serum

922

5194

1.83

61.24

1.3

0.66

1.09

u/ml

0.72

432

(3003888) Timothy IgE Ab [Units/volume] in Serum

475

2114

2.29

60.41

1.1

3.84

4.32

u/ml

0.32

265

1070

(3003327) Ova and parasites identified in Stool by Light microscopy

817

4462

1.89

59.83

1.8

1.7

—

(3007461) Platelets [#/volume] in Blood

12871

124153

2.48

59.77

31.1

24.7

252.48

254.81

e9/l

3.95

12718

121774

(3035941) MCH [Entitic mass]

12871

124180

2.47

59.25

31.0

24.6

30.33

30.29

1.94

12803

122985

(3024731) MCV [Entitic mean volume] in Red Blood Cells

12871

124183

2.47

59.20

31.0

24.6

91.34

91.16

4.76

12803

122984

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

12871

124192

2.47

59.03

31.8

25.1

40.17

40.45

1.62

12805

122949

(3010813) Leukocytes [#/volume] in Blood

12872

124207

2.47

59.01

31.1

24.7

6.59

6.70

e9/l

8.43

12684

121429

(3026361) Erythrocytes [#/volume] in Blood

12871

124194

2.47

58.99

31.1

24.7

4.45

e12/l

0.16

12681

121438

(3000963) Hemoglobin [Mass/volume] in Blood

12872

124211

2.47

58.93

31.3

24.9

133.89

133.98

g/l

0.29

12812

123034

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5448

45155

1.35

58.52

4.2

3.7

115.00

57.74

ng/l

0.29

3558

30823

(3027135) IgG subclass 1 [Mass/volume] in Serum

332

1272

2.65

58.42

1.4

6.23

6.77

g/l

1.86

249

917

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

744

3972

1.93

58.37

1.9

1.8

1.19

1.20

g/l

0.11

712

3782

(3010726) Horse dander IgE Ab [Units/volume] in Serum

444

1949

2.32

58.31

1.2

1.1

1.11

1.30

u/ml

0.33

244

953

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

459

2045

2.29

58.22

1.2

1.1

22.02

13.59

au/ml

1.54

106

483

(3022145) Colonoscopy Study observation

2051

14334

1.51

58.19

1.3

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

331

1272

2.64

57.89

1.5

1.4

0.39

0.40

g/l

0.19

249

913

(3028192) IgG subclass 2 [Mass/volume] in Serum

330

1272

2.64

57.37

1.5

1.4

2.75

2.91

g/l

1.09

249

916

(3007853) Bacteria identified in Skin by Aerobe culture

2058

14433

1.50

57.34

1.9

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

4036

32011

1.38

57.09

2.8

2.7

328.92

334.46

umol/l

3.05

3557

28239

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1495

9795

1.59

56.61

3.7

3.8

79.02

89.07

ng/l

4.49

1318

8463

(3026782) Osmolality of Urine

3047

23110

1.41

56.07

3.1

3.0

520.91

522.12

mosm/kgh2o

0.11

2675

20260

(3008401) Mugwort IgE Ab [Units/volume] in Serum

452

2043

2.26

55.39

1.1

0.70

0.91

u/ml

0.59

214

864

(1002224) Polysomnography panel

941

5493

1.77

55.33

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1201

7503

1.66

55.07

2.0

1.19

1.36

g/l

2.75

1122

6887

(3023368) Bacteria identified in Blood by Culture

4106

32829

1.36

54.65

4.7

4.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

686

3652

1.93

54.21

2.8

2.3

0.01

0.02

g/l

0.94

617

3269

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

12020

113812

1.63

54.05

5.7

5.1

4.63

4.68

mmol/l

7.79

11361

106654

(4062490) Immunoglobulin typing, IgG

319

1247

2.60

53.91

1.5

1.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

231

763

3.06

53.56

7.7

7.0

16.29

108.57

ug/l

1.35

127

499

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1035

6289

1.70

52.64

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

11954

113180

1.60

52.04

5.6

5.0

1.51

1.50

mmol/l

2.71

11251

105471

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

10399

95848

1.40

51.74

26.8

20.7

331.54

331.66

g/l

0.74

10354

95355

(3022948) Iron [Moles/volume] in Serum or Plasma

2837

21533

1.40

51.25

2.6

13.47

12.97

umol/l

3.24

2670

20042

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

658

3522

1.91

51.12

2.8

2.3

0.00

g/l

0.15

580

3061

(40760892) CBC W Ordered Manual Differential panel - Blood

3484

27435

1.37

50.14

4.8

4.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

619

3273

1.94

49.87

2.8

2.3

0.00

g/l

-0.00

579

3051

(3024980) IgG subclass 4 [Mass/volume] in Serum

441

2072

2.17

49.11

1.6

1.5

0.62

0.74

g/l

2.24

347

1602

(3000570) Elastase.pancreatic [Mass/mass] in Stool

693

3836

1.85

48.48

1.5

1.4

281.28

271.93

ug/g

0.55

407

2202

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1361

9045

1.56

48.00

1.3

1.2

112.43

145.30

u/ml

2.91

509

3456

(3023430) Cat dander IgE Ab [Units/volume] in Serum

369

1635

2.29

47.42

1.1

2.89

3.81

u/ml

0.70

179

690

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

6564

56945

1.30

47.16

2.9

2.8

—

estimate

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1561

10730

1.52

47.12

8.0

7.6

1.27

1.31

mmol/l

0.95

1523

10532

(3014133) Dog dander IgE Ab [Units/volume] in Serum

384

1736

2.25

47.04

1.1

4.02

3.33

u/ml

0.17

206

813

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

210

716

2.96

46.10

1.1

8.68

8.00

nmol/l

0.06

132

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

752

4339

1.78

45.83

2.8

2.4

0.54

0.85

g/l

2.44

659

3713

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2628

20051

1.39

45.20

2.6

2.35

2.34

g/l

0.84

2436

18503

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

801

4751

1.73

44.30

2.7

2.3

2.87

2.89

g/l

0.23

736

4312

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

458

2276

2.05

44.01

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

458

2276

2.05

44.01

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

999

6324

1.63

43.09

2.4

—

(3042936) Bacteria identified in Isolate by Culture

2287

17167

1.40

43.08

2.0

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1490

10355

1.49

42.37

2.7

66.26

66.32

g/l

0.12

1380

9461

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

333

1485

2.27

42.17

1.1

1.0

0.12

0.30

u/ml

1.12

131

464

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

829

5054

1.68

41.38

2.7

2.3

7.10

7.42

g/l

7.63

764

4611

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

557

3024

1.88

41.36

1.2

1.3

51.92

45.06

u/ml

0.37

304

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

828

5049

1.68

41.30

2.7

2.3

4.13

4.23

g/l

2.97

763

4609

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

827

5043

1.68

41.24

2.7

2.3

3.62

3.69

g/l

0.77

761

4602

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1107

7259

1.57

41.12

1.9

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1321

9028

1.51

40.64

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

364

1713

2.16

40.39

1.1

3.31

2.58

0.49

279

(3000991) Gas panel - Venous blood

1484

10399

1.48

40.38

9.1

8.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

705

4140

1.74

40.34

2.8

2.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

587

3270

1.83

40.16

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

11411

107960

1.42

39.86

4.6

4.3

1.24

1.27

mmol/l

6.60

10618

99614

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

582

3248

1.83

39.58

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

726

4335

1.71

39.11

2.8

2.3

9.58

10.14

g/l

3.64

657

3840

(3014576) Chloride [Moles/volume] in Serum or Plasma

2188

16540

1.39

39.10

7.7

7.3

104.49

104.31

mmol/l

1.08

2188

16534

(42529406) Shigella sp [Presence] in Stool by Culture

584

3277

1.82

39.01

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

692

4085

1.73

38.85

1.3

4.62

41.99

u/ml

12.52

225

(3023420) DNA double strand Ab [Units/volume] in Serum

871

5486

1.63

38.22

2.0

1.8

16.79

7.21

iu/ml

0.84

195

1314

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2395

18445

1.36

38.01

2.7

22.63

22.31

0.57

2251

17102

(3019309) Folate [Moles/volume] in Red Blood Cells

2623

20508

1.35

37.71

1.8

1.7

1146.61

1166.55

nmol/l

0.53

1969

15621

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

846

5321

1.63

37.32

2.0

39.02

39.65

u/l

0.41

761

4737

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

779

4805

1.66

37.11

1.6

15.52

16.95

u/ml

0.17

149

1097

(46235355) HIV 1 and 2 tests - Meaningful Use set

2603

20446

1.34

36.05

2.0

1.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1333

9344

1.47

35.99

3.2

2.9

149.69

188.22

ng/l

4.02

1221

8587

(3044640) Blood type and Crossmatch panel - Blood

4684

39806

1.27

35.97

2.6

2.4

—

(3025941) Bacteria identified in Stool by Culture

998

6588

1.56

35.84

1.3

1.2

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

825

5215

1.62

35.63

1.8

1.6

15.09

14.13

iu/ml

0.05

143

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3654

30126

1.29

35.61

2.5

2.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

921

5984

1.58

35.44

1.2

1.1

342.50

179.54

titre

0.39

150

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1039

6940

1.54

35.37

4.4

4.1

24.53

24.24

mmol/l

2.71

1023

6865

(3036489) Thrombin time

723

4459

1.66

34.43

2.0

2.1

21.04

20.98

0.07

645

3928

(44813793) Dust mix specific IgE antibody measurement

208

844

2.49

32.66

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

223

935

2.41

32.61

1.0

1.1

6.91

8.81

iu/ml

0.64

250

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

585

3460

1.72

32.58

2.4

2.5

184.11

193.05

1.66

554

3289

(3027801) Oxygen [Partial pressure] in Arterial blood

1846

13975

1.37

32.09

8.0

7.6

12.29

12.51

kpa

1.03

1783

13468

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1846

13980

1.37

32.01

8.0

7.6

5.03

5.09

kpa

1.79

1785

13477

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1038

7077

1.51

32.00

2.4

2.2

12.53

12.34

nmol/l

0.30

926

6301

(3024891) Influenza virus A+B Ag [Presence] in Specimen

519

2993

1.76

31.61

1.2

1.1

—

(3019977) pH of Arterial blood

1837

13975

1.37

30.86

8.1

7.6

7.43

7.42

5.93

935

7629

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2076

16114

1.34

30.56

5.7

5.8

1.02

1.04

mmol/l

2.78

1923

15009

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

703

4442

1.62

30.35

1.3

—

(3003396) Base excess in Arterial blood by calculation

1819

13853

1.36

30.31

8.0

7.6

0.95

mmol/l

0.02

1570

11462

(3027945) Reticulocytes/Erythrocytes in Blood

1839

14040

1.36

30.15

2.5

1.76

1.79

0.67

1659

12522

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

604

3687

1.67

29.90

2.1

2.0

3.68

7.53

iu/l

0.88

264

1522

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

602

3676

1.67

29.76

2.2

95.83

93.44

2.12

579

3546

(3052851) Hemolysis interference index of Serum or Plasma

556

3346

1.69

29.05

3.2

3.1

2.57

2.01

index

0.90

286

1692

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

616

3814

1.65

28.85

1.3

12.39

4.95

u/ml

0.57

367

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1029

7161

1.47

28.57

9.8

9.4

24.43

24.29

mmol/l

0.74

1006

7031

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2088

16371

1.33

28.49

3.6

3.4

0.70

0.78

ug/l

3.40

1465

11158

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

613

3809

1.64

28.31

1.3

9.54

6.62

u/ml

0.31

569

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

473

2759

1.74

27.69

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

547

3340

1.67

27.05

1.3

15.10

14.30

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

356

1926

1.87

26.78

1.4

—

(3002032) Base excess in Venous blood by calculation

1536

11602

1.37

26.73

4.2

3.9

2.03

1.84

mmol/l

1.48

1373

10171

(3012544) pH of Venous blood

1589

12088

1.36

26.40

4.2

3.9

7.38

0.22

850

6927

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1305

9623

1.40

26.29

2.4

2.3

5.84

7.10

ug/l

1.50

1128

8429

(3008898) HLA-B27 [Presence]

655

4215

1.58

26.17

1.1

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1105

7925

1.43

26.09

7.7

8.1

25.02

24.82

mmol/l

1.20

1096

7878

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1565

11926

1.35

25.66

4.2

3.9

5.87

5.82

kpa

1.03

1524

11635

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

572

3580

1.62

25.66

2.7

2.5

3.61

g/l

0.00

553

3407

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

505

3076

1.67

25.22

1.3

490.91

539.68

mg/l

1.33

488

2938

(3016502) Oxygen saturation in Arterial blood

1618

12429

1.34

25.13

8.4

7.9

95.99

95.63

1.76

1570

12004

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

172

724

2.39

25.05

1.4

1.5

5.23

6.11

u/l

0.95

145

625

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1526

11630

1.35

24.97

8.8

8.4

122.05

120.35

g/l

2.95

1499

11365

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

277

1415

1.98

24.77

1.6

1.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

519

3202

1.65

24.66

1.3

6.98

4.14

u/ml

0.32

212

(3014007) Fractional oxyhemoglobin in Arterial blood

1094

7913

1.42

24.58

9.9

9.6

94.33

93.99

1.24

1094

7886

(4094501) Cardiovascular stress test using bicycle ergometer

524

3249

1.64

24.41

1.1

—

(3002256) Pathology report gross observation

2113

16925

1.30

24.27

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1802

14140

1.32

24.08

4.1

4.5

231.04

244.64

u/l

6.33

1721

13403

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

445

2662

1.70

23.80

1.3

1.4

24.03

34.28

e6/l

0.30

318

1950

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

245

1218

2.03

23.67

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

580

3717

1.59

23.59

1.3

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

985

7062

1.43

23.22

1.4

28.65

30.50

iu/l

0.98

843

6119

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

529

3329

1.61

23.22

2.0

2.1

11.33

11.58

mg/l

0.32

486

3110

(3049717) Cytology report of Urine Cyto stain

641

4220

1.55

23.16

2.5

2.7

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

182

815

2.25

23.01

1.1

16.87

18.73

u/ml

0.34

343

(40759836) Histone Ab [Presence] in Serum by Immunoblot

219

1056

2.09

22.99

1.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

962

6890

1.43

22.80

10.4

9.7

16.28

15.92

4.26

941

6645

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

446

2701

1.67

22.79

1.3

1.4

666.88

2889.98

e6/l

0.91

343

2120

(3017732) Neutrophils [#/volume] in Blood

1987

15918

1.29

22.65

2.8

3.2

4.54

4.43

e9/l

0.17

1733

13765

(40768443) Skin Pathology biopsy report

827

5776

1.46

22.43

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

221

1080

2.06

22.39

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

416

2486

1.70

22.35

1.8

45.41

44.49

nmol/l

0.28

411

2406

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2665

22171

1.25

22.20

5.1

4.7

22.63

22.08

1.03

1296

11405

(3017143) Hepatitis C virus Ab [Presence] in Serum

1704

13410

1.31

22.16

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

190

880

2.18

22.14

1.1

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

395

2335

1.71

22.10

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

244

1242

1.98

22.09

1.1

—

3.95

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

539

3449

1.59

22.07

1.6

1.4

12.89

15.24

iu/ml

0.22

(3018333) Ribosomal P Ab [Presence] in Serum

205

984

2.10

21.80

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3248

27670

1.23

21.69

6.4

5.8

3.41

3.16

ug/l

0.09

2965

24922

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1041

2.06

21.60

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

505

3199

1.60

21.58

1.1

6.70

6.71

eliau/ml

0.00

416

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1043

2.06

21.49

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

209

1017

2.07

21.44

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

207

1004

2.08

21.42

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

323

2.96

21.21

1.7

2.2

0.55

0.49

e9/l

0.04

150

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5419

48580

1.20

21.20

4.5

3.9

2.19

0.54

estimate

1.16

1264

10891

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

235

1202

1.97

21.01

1.1

—

68.15

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

159

701

2.28

20.91

1.5

7.42

8.01

ug/l

0.19

144

636

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1500

11701

1.32

20.71

2.3

2.0

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1302

9957

1.34

20.63

2.8

2.7

69.23

66.64

ml/min/173m2

1.81

631

4229

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

322

1834

1.77

20.56

1.8

1.9

176.97

193.17

pmol/l

2.02

298

1722

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

498

3191

1.58

20.29

1.4

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

437

2714

1.63

20.27

1.2

1.3

3.64

3.74

mmol/l

1.53

407

2573

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

414

2539

1.65

20.18

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1369

10587

1.33

20.06

2.1

2.0

—

(3045414) Leukocytes [Presence] in Urine

1549

12251

1.30

19.24

2.2

2.1

0.04

0.02

estimate

0.53

321

2438

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.08

19.24

1.2

0.71

0.58

iu/ml

0.15

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

181

875

2.08

18.96

1.9

2.1

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

1.48

0.98

mg/l

0.27

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

0.53

1.42

mg/l

0.83

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

4.19

4.44

mg/l

0.07

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

2.16

3.56

mg/l

0.74

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

2.08

2.12

mg/l

0.01

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

1.26

2.31

mg/l

0.70

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

2.99

3.09

mg/l

0.03

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

1.60

1.99

mg/l

0.25

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.84

18.67

1.3

1.6

2.04

2.59

mg/l

0.24

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

215

1114

1.95

18.57

1.1

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

102

4.42

18.40

1.2

1.1

1.40

1.80

iu/ml

0.85

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

476

3089

1.56

18.38

1.4

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

1390

10902

1.31

18.34

2.4

2.6

69.06

69.53

e9/l

0.18

972

8016

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

334

1992

1.69

18.15

1.4

7.33

14.18

u/ml

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

577

3918

1.49

18.05

1.7

298.24

305.81

mu/l

0.21

535

3536

(3009214) Lutropin [Units/volume] in Serum or Plasma

464

3014

1.56

17.85

1.3

1.4

12.78

12.39

u/l

0.21

362

2437

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

167

802

2.10

17.83

1.8

2.5

493.01

523.82

e6/l

0.42

130

642

(3019150) Specific gravity of Urine by Refractometry

3291

28525

1.20

17.81

4.7

4.2

1.02

1.18

kg/l

1.09

2237

18958

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.62

17.69

1.3

1.6

0.84

2.27

mg/l

1.44

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

381

2368

1.63

17.66

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

171

832

2.07

17.64

1.9

2.7

237.75

229.09

e6/l

0.25

140

709

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

961

7199

1.36

17.36

2.2

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

486

3211

1.53

17.32

1.3

—

(4015189) Microbial culture of sputum

283

2.87

17.31

2.6

2.2

—

(3024928) Oxygen saturation in Venous blood

452

2945

1.55

17.16

4.4

3.3

60.77

61.13

0.13

430

2860

(44790047) Parainfluenza type 1 nucleic acid detection

269

1539

1.76

17.00

1.4

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

839

2.04

16.90

1.1

—

(3023410) Appearance of Cerebral spinal fluid

218

1175

1.87

16.76

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

268

1539

1.76

16.72

1.4

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

268

1539

1.76

16.72

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

268

1539

1.76

16.72

1.4

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

789

5760

1.39

16.71

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

438

2854

1.55

16.64

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

1266

9930

1.30

16.63

3.7

3.3

4.41

4.52

kpa

1.13

1227

9669

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

103

418

2.48

16.42

1.3

1.2

108.49

110.71

0.36

371

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

183

940

1.96

16.27

1.1

30.91

42.21

mg/l

5.50

156

789

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

306

1837

1.68

16.27

1.2

3.26

3.53

u/ml

0.12

115

667

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

177

908

1.96

15.81

1.1

224.50

261.86

mg/l

2.87

161

800

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

106

446

2.39

15.64

1.3

1.2

0.31

0.30

g/l

0.31

357

(3011412) CD3 cells [#/volume] in Blood

212

1160

1.84

15.57

1.9

2.4

1185.40

1205.98

e6/l

0.12

181

1020

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2134

17933

1.23

15.55

1.6

—

(3013512) EKG study

4600

41430

1.17

15.41

3.8

3.6

0.67

0.76

—

104

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

794

5883

1.37

15.36

2.1

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1152

9017

1.30

15.34

1.5

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

297

1800

1.66

15.26

1.2

3.29

4.08

u/ml

0.93

142

820

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

307

1884

1.64

15.03

1.2

5.12

7.92

u/ml

0.37

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2952

25686

1.19

14.85

1.7

33588859.41

34721234.95

pmol/l

0.04

2483

21454

(3039162) Centromere protein B Ab [Units/volume] in Serum

281

1695

1.67

14.72

1.3

33.23

63.54

u/ml

1.45

108

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

249

1455

1.73

14.67

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

370

2398

1.56

14.44

2.1

1.9

5.10

5.03

mmol/24h

0.09

330

2138

(3009508) Creatinine [Moles/volume] in Urine

4617

41750

1.16

14.41

3.4

7.23

mmol/l

0.02

3908

35229

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

300

1852

1.63

14.37

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

321

2021

1.60

14.20

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

211

1188

1.79

14.16

3.3

3.1

14.98

13.72

index

0.56

112

656

(3020779) Urea [Moles/volume] in Serum or Plasma

1319

10670

1.26

13.47

6.6

7.3

9.15

9.87

mmol/l

3.43

1258

10219

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

113

522

2.17

13.45

1.8

2.5

757.74

165.94

ug/l

0.37

107

491

(3013005) Retinol [Moles/volume] in Serum or Plasma

118

555

2.14

13.42

1.3

1.8

2.03

1.96

umol/l

0.41

108

504

(21491868) Cryoglobulin [Mass/volume] in Serum

433

2.27

13.01

1.2

0.78

0.13

g/l

—

(3035637) Corticotropin [Mass/volume] in Plasma

266

1635

1.64

13.01

1.6

30.08

28.81

ng/l

0.10

266

1629

(3020874) Milk IgE Ab [Units/volume] in Serum

143

732

1.96

12.95

1.1

4.96

1.63

u/ml

0.36

230

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

342

2.44

12.91

1.3

152.35

127.41

nmol/l

0.61

247

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

175

960

1.83

12.84

1.4

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

3975

35821

1.16

12.54

4.8

4.2

0.00

estimate

4.50

1458

12425

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

176

3.02

12.50

1.3

35.26

42.08

mg/l

0.55

152

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

259

2.63

12.46

1.0

1.1

28.14

33.55

iu/ml

0.44

259

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

132

667

1.99

12.42

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

739

5614

1.34

12.17

1.7

1.53

1.55

g/l

0.35

642

4829

(4027681) Cerebrospinal fluid IgG ratio and IgG index

135

693

1.96

12.16

1.3

1.2

0.52

0.59

ratio

1.44

399

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

185

2.93

12.08

1.2

1.0

0.96

5.55

u/ml

0.68

114

(3034860) Kappa light chains.free [Mass/volume] in Serum

578

4234

1.38

12.04

3.7

3.4

49.09

64.86

mg/l

0.55

506

3597

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

132

680

1.95

11.78

1.8

2.1

101.45

99.45

0.27

121

631

(3000475) Leukocytes [#/volume] in Synovial fluid

443

3110

1.44

11.78

1.6

13185.38

13187.79

e6/l

0.00

306

2171

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

576

4233

1.38

11.77

3.6

3.4

37.03

45.13

mg/l

0.80

503

3597

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

577

4242

1.38

11.76

2.0

2.2

367.47

592.37

ug/l

1.23

547

4007

(3041096) Erythrocytes [Presence] in Urine by Automated

3837

34617

1.15

11.74

3.8

3.4

0.76

0.27

estimate

0.79

1282

10634

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

199

1167

1.72

11.68

1.3

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

494

3552

1.41

11.50

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

277

1774

1.57

11.49

1.1

—

(4195642) Thrombophilia screening test

266

1690

1.59

11.42

1.2

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

322

2139

1.52

11.33

1.3

1.4

153.97

153.65

au/ml

0.02

600

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

516

3770

1.38

10.95

3.6

3.2

5.97

4.31

ratio

0.23

275

2200

(3022621) pH of Urine by Test strip

1208

9905

1.24

10.90

2.8

2.7

6.04

6.07

0.59

764

6606

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

154

2.99

10.75

1.1

0.03

0.31

u/ml

0.90

101

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

244

1542

1.59

10.74

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1438

12026

1.22

10.74

2.3

2.2

0.22

0.21

g/l

3.36

1344

11233

(3012516) Albumin [Mass/volume] in Urine

4293

39221

1.14

10.71

3.5

37.18

45.22

mg/l

1.95

2574

24239

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

263

1695

1.56

10.65

1.1

119.83

117.99

0.43

240

1531

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

236

1485

1.60

10.58

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

347

2377

1.47

10.54

1.3

1.4

—

(3042631) Mycobacterium sp identified in Specimen

248

1584

1.58

10.45

3.0

2.8

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

400

2822

1.43

10.40

1.9

1.8

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

310

2082

1.50

10.39

1.5

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

125

664

1.89

10.25

1.0

1.1

1.03

1.13

u/l

1.31

268

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

210

1295

1.63

10.24

1.1

93.46

96.25

0.72

196

1221

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1565

13255

1.20

10.24

1.7

1.44

0.07

1354

11588

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

108

547

1.98

10.19

1.1

6.44

7.03

u/ml

0.07

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.48

10.13

2.0

1.8

46.94

47.32

umol/l

0.02

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1225

10144

1.23

10.06

2.7

2.4

0.39

0.41

e6/l

0.13

1144

9692

(3019832) Treponema pallidum Ab [Presence] in Serum

1213

10035

1.23

10.06

1.8

1.7

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

409

2.13

10.03

1.1

1.2

113.31

110.07

0.37

371

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

507

3755

1.36

9.92

1.2

1.3

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

130

708

1.84

9.88

1.1

1.0

1.82

1.07

u/ml

0.37

164

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

399

2.14

9.85

1.0

1.1

92.76

89.04

0.51

179

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

148

843

1.76

9.71

1.3

1.5

12.45

12.57

umol/l

0.08

139

788

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

395

2.13

9.70

1.0

1.2

93.12

90.52

0.20

185

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

537

4028

1.35

9.68

1.5

0.27

8.71

iu/ml

1.09

113

772

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

254

1662

1.54

9.65

1.1

2.09

3.41

eliau/ml

2.24

106

779

(4268621) Lupus anticoagulant assay

207

1301

1.60

9.39

2.2

2.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

323

2238

1.45

9.30

1.2

1.3

275.38

270.26

u/ml

0.10

199

1402

(3006184) Hemoglobin [Mass/volume] in Capillary blood

409

2963

1.39

9.19

2.3

129.20

128.53

g/l

0.22

281

2268

(3020682) Albumin/Creatinine [Ratio] in Urine

4331

39882

1.13

9.17

4.1

6.72

8.57

mg/mmol

1.88

2511

24122

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

341

2396

1.43

9.12

1.2

—

55.55

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

119

648

1.84

9.09

1.1

1.0

0.55

0.84

u/ml

0.21

144

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

115

620

1.86

9.07

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

601

4635

1.31

8.96

1.6

0.32

0.31

mg/l

0.17

216

2084

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

107

570

1.88

8.77

3.8

4.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

488

3666

1.34

8.75

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

228

1493

1.54

8.69

1.4

1.5

—

(4024509) Urine culture

734

5835

1.27

8.67

2.0

1.9

—

(44806420) Estimation of glomerular filtration rate

215

1395

1.55

8.54

2.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

273

1863

1.48

8.54

1.4

1.3

0.61

2.40

nmol/l

0.93

257

1805

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

163

992

1.65

8.46

1.3

1.2

208.00

171.14

titre

0.21

158

(3011288) Drugs identified in Urine by Screen method Nominal

372

2692

1.39

8.45

1.9

2.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

277

1904

1.46

8.36

1.4

1.3

0.21

0.23

nmol/l

0.10

129

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

241

1616

1.50

8.24

1.4

1.3

0.18

0.20

nmol/l

0.68

178

1246

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

522

1.88

8.07

1.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

474

3593

1.33

8.03

1.2

1070.83

896.85

titre

0.23

124

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

161

991

1.63

8.02

1.3

1.2

74.00

163.14

titre

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

385

2.03

8.01

2.1

2.4

1.22

1.04

ug/l

0.28

368

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

172

1077

1.60

8.00

1.3

1.2

105.67

110.40

pmol/l

0.77

172

1077

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

153

2.68

7.96

1.0

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

3.84

7.95

1.3

1.2

2.46

1.62

u/ml

0.22

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

353

2562

1.39

7.91

4.9

5.5

984.93

1652.76

iu/ml

0.36

357

(3007566) Smooth muscle Ab [Titer] in Serum

475

3610

1.33

7.91

1.2

99.71

126.49

titre

0.51

345

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

581

4558

1.29

7.67

3.4

3.5

334.88

1811.14

u/ml

1.61

497

3905

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

163

2.58

7.57

1.3

1.4

0.25

0.27

nmol/l

0.11

111

(3017181) Myelocytes/Leukocytes in Blood

1316

11279

1.19

7.49

4.5

0.88

0.96

0.45

361

3406

(3011985) Renin [Units/volume] in Plasma

267

1864

1.44

7.48

1.5

42.76

62.85

mu/l

1.60

232

1679

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

113

645

1.76

7.47

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

437

3312

1.33

7.44

1.4

—

(3037756) Immunofixation for Serum or Plasma

348

2551

1.37

7.37

1.6

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

495

3834

1.30

7.22

2.8

3.2

0.35

iu/ml

0.06

254

2120

(3003740) Influenza virus B Ag [Presence] in Specimen

284

2020

1.41

7.20

1.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

888

7369

1.22

7.16

6.6

6.9

24.79

24.55

mmol/l

1.23

860

7057

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

249

1731

1.45

7.16

1.1

1.50

1.51

g/l

0.28

229

1580

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

133

2.71

7.15

1.4

1.3

—

(3002179) Metamyelocytes/Leukocytes in Blood

1253

10738

1.18

7.14

4.3

0.74

0.73

0.03

339

3246

(3021440) Promyelocytes/Leukocytes in Blood

1259

10809

1.18

7.03

4.5

0.12

0.02

307

2944

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

152

956

1.60

7.00

1.2

1.3

1.97

2.10

mmol/l

0.77

141

892

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1382

11977

1.17

6.88

3.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

282

2021

1.40

6.87

1.1

—

(3025159) Blasts/Leukocytes in Blood

1270

10934

1.18

6.85

4.8

4.7

0.07

0.29

2.63

292

2821

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

172

2.45

6.81

1.3

1.7

169450.47

293843.00

nmol/l

0.23

146

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

109

636

1.72

6.72

1.5

1.4

3.87

4.39

umol/l

0.88

572

(3001019) Free T4 and TSH panel - Serum or Plasma

756

6214

1.23

6.71

1.9

1.7

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

307

2256

1.37

6.46

1.3

55.56

172.92

titre

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

127

782

1.63

6.42

1.9

2.6

0.74

0.69

e9/l

0.44

121

740

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

260

2.12

6.41

1.1

1.2

102.29

78.29

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

157

1018

1.55

6.38

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

157

1018

1.55

6.38

1.3

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

157

1018

1.55

6.38

1.3

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

564

1.74

6.37

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

564

1.74

6.37

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

295

2.04

6.32

1.1

0.94

4.76

u/ml

0.68

156

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

149

958

1.56

6.29

1.0

1.1

292.41

294.16

mg/l

0.11

135

871

(3027231) Wheat IgE Ab [Units/volume] in Serum

218

2.21

6.19

1.1

1.0

0.39

2.32

u/ml

0.88

178

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

304

2247

1.36

6.18

1.2

1.3

223.48

293.81

titre

0.25

177

(37208534) Antinuclear antibody arbitrary concentration in serum

409

1.86

6.17

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

361

2739

1.33

6.17

1.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

242

1723

1.41

6.17

1.4

1.3

304.22

334.44

pmol/l

0.52

206

1470

(3004119) Hemoglobin [Mass/volume] in Venous blood

875

7361

1.20

6.16

4.0

3.4

129.58

128.51

g/l

0.76

848

7156

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

173

1156

1.50

6.14

1.4

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

110

664

1.66

6.03

2.4

2.8

43.31

39.62

1.33

381

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

184

1250

1.48

6.03

1.3

1.7

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

328

1.96

6.02

1.1

68.14

61.39

u/ml

0.28

320

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

206

1432

1.45

6.00

1.2

59.46

61.73

u/l

0.20

179

1252

(3005011) Chlamydia sp Ab [Titer] in Serum

159

2.39

5.93

1.8

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

795

6659

1.21

5.87

3.7

3.5

1.85

1.81

mmol/l

0.12

618

4924

(3020891) Body temperature

677

5582

1.22

5.87

4.0

4.6

36.92

36.91

°c

0.36

672

5529

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

511

1.75

5.87

1.3

155.13

175.62

pmol/l

0.48

511

(3028626) Oxygen [Partial pressure] in Capillary blood

387

2989

1.30

5.85

3.9

3.2

8.40

8.19

kpa

1.98

381

2922

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

174

1177

1.48

5.84

1.4

1.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

334

2534

1.33

5.74

1.7

1.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

436

3431

1.28

5.71

1.6

1.7

—

(3009343) pH of Capillary blood

901

7657

1.19

5.69

3.9

3.6

7.42

3.42

769

6349

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

100

599

1.67

5.67

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

524

1.72

5.67

1.6

2.8

—

(3028707) Methadone [Presence] in Urine by Screen method

229

1642

1.40

5.64

1.8

2.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

201

1409

1.43

5.63

1.3

1.2

11.54

45.60

u/ml

3.78

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

130

833

1.57

5.62

1.3

1.2

85.11

86.82

u/l

0.08

114

706

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

926

7897

1.19

5.62

3.9

3.6

5.11

5.15

kpa

0.95

896

7542

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

177

1214

1.46

5.56

1.2

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

127

815

1.56

5.47

1.3

1.2

24.53

25.01

u/l

0.04

111

674

(3020717) Zinc [Moles/volume] in Serum or Plasma

120

761

1.58

5.44

1.3

1.5

28.38

23.18

umol/l

0.99

113

703

(3025130) Human papilloma virus identified in Specimen

286

2141

1.34

5.41

1.6

1.8

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

509

1.71

5.40

1.1

105.80

384.81

ng/l

1.03

140

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

128

827

1.55

5.36

1.2

76.33

83.64

0.45

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

259

2.01

5.35

1.1

1.2

106.20

72.63

—

(21494755) Public health laboratory ask at order entry panel

882

10292

0.85

5.30

1.4

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

281

1.96

5.27

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1141

9951

1.16

5.25

4.3

3.8

1.22

1.23

mmol/l

3.75

981

8561

(3047181) Lactate [Moles/volume] in Blood

447

3570

1.26

5.22

6.1

5.6

1.27

1.31

mmol/l

0.46

406

3153

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

583

1.65

5.21

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

121

2.48

5.10

1.1

0.05

0.04

u/ml

0.09

121

(3013247) Albumin in CSF/Albumin in Serum or Plasma

231

2.04

5.03

1.1

1.0

6.31

7.40

mg/g

0.70

220

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

268

2016

1.34

4.95

2.5

2.6

286.55

1990.09

u/ml

1.93

109

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

105

664

1.59

4.87

1.2

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

271

2051

1.33

4.81

1.4

0.37

0.39

nmol/l

0.17

206

1535

(3033923) Metanephrine [Moles/time] in 24 hour Urine

242

1.99

4.81

1.0

1.1

1.13

0.65

umol/24h

0.74

107

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1532

13727

1.13

4.76

8.0

6.8

—

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

5.72

4.74

1.1

1.0

0.05

0.48

u/ml

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

553

1.63

4.71

1.1

3.33

3.68

iu/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

102

2.55

4.70

1.0

0.11

1.62

u/ml

0.88

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

249

1871

1.34

4.66

1.2

0.36

1.06

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

510

4192

1.23

4.63

2.9

24.88

24.82

mmol/l

0.14

502

4125

(40767503) Oxygen content in Capillary blood by calculation

320

2494

1.29

4.61

2.8

2.6

16.57

16.29

0.98

313

2450

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

580

1.61

4.59

1.3

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

8.19

4.55

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.55

4.53

1.0

3.07

0.70

u/ml

0.40

(3023511) Choriogonadotropin [Units/volume] in Urine

266

2028

1.32

4.52

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

370

1.76

4.51

1.1

1.0

6.36

10.18

u/ml

1.07

239

(3008295) Osmolality of Serum or Plasma

186

1342

1.39

4.51

1.5

1.4

278.22

277.41

mosm/kgh2o

0.19

134

1027

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

348

1.79

4.51

1.7

1.6

0.40

0.39

ug/l

0.03

245

(3045683) HLA typing for celiac disease panel - Blood or Tissue

109

710

1.54

4.48

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

128

863

1.49

4.47

1.3

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

530

1.63

4.47

1.4

1.7

30.07

29.39

umol/l

0.28

499

(3038026) Centromere Ab [Units/volume] in Serum

147

1022

1.44

4.40

1.3

1.2

64.88

54.30

u/ml

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.62

4.38

1.0

0.37

1.31

u/ml

0.43

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

112

2.41

4.37

1.0

0.07

4.31

u/ml

0.51

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

119

2.36

4.31

1.1

1.0

1.04

0.69

u/ml

0.26

(3021901) Oxygen saturation in Capillary blood

318

2505

1.28

4.24

2.9

3.0

91.21

89.86

4.42

313

2444

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

139

2.23

4.23

1.0

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

108

2.41

4.21

1.1

87.38

89.78

titre

0.06

108

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

508

1.62

4.20

1.3

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

462

1.65

4.19

1.5

1.4

88.05

259.90

nmol/24h

1.59

462

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

427

1.67

4.09

1.0

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

125

856

1.46

4.08

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

223

1687

1.33

4.04

1.4

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

521

1.60

4.04

2.5

2.1

56.51

61.96

ug/l

0.34

507

(3008536) Aspergillus sp Ab [Presence] in Serum

244

1.89

4.04

1.3

2.0

—

(3027315) Oxygen [Partial pressure] in Blood

306

2419

1.27

3.99

3.5

4.0

8.74

8.60

kpa

0.48

297

2373

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

618

1.54

3.97

1.7

1.79

5.30

nmol/l

2.66

508

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

438

3609

1.22

3.94

3.6

3.3

1.46

1.55

mg/l

1.60

390

3297

(3028271) Lactate [Moles/volume] in Capillary blood

238

1825

1.31

3.93

1.9

1.8

1.55

1.68

mmol/l

2.04

233

1785

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

403

1.67

3.88

1.3

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.56

3.87

1.1

1.0

0.22

0.23

u/ml

0.02

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

255

1.85

3.87

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

184

1363

1.35

3.86

1.8

89.79

89.76

0.02

179

1346

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

504

4225

1.20

3.81

1.6

1.7

3.40

4.52

mg/l

2.41

373

3194

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

117

804

1.46

3.78

1.0

398.01

334.50

ng/l

0.30

565

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

152

1096

1.39

3.77

2.4

3.0

—

(1616796) Gas panel - Central venous blood

331

2661

1.25

3.77

3.6

3.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

108

2.32

3.74

1.0

1.2

1.55

1.67

umol/24h

0.35

108

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

172

1268

1.36

3.73

1.6

1.7

1040.00

1570.53

titre

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

3.83

3.68

1.0

0.13

0.03

u/ml

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

256

2006

1.28

3.62

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

161

1182

1.37

3.60

1.3

1.2

117.63

71.64

u/ml

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

716

1.47

3.56

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

104

708

1.47

3.55

3.4

19.88

26.07

mu/l

1.65

673

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

116

808

1.44

3.52

1.0

800.76

732.05

ng/l

1.01

549

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

552

4702

1.18

3.52

2.1

2.0

—

(3012501) Base excess in Blood by calculation

299

2399

1.25

3.49

3.5

3.9

2.32

2.54

mmol/l

0.83

208

1631

(3039000) Anion gap in Blood by calculation

303

2435

1.25

3.49

7.4

6.6

11.38

11.25

mmol/l

0.29

280

2182

(3018572) Chloride [Moles/volume] in Blood

303

2436

1.25

3.48

7.4

6.6

104.61

105.17

mmol/l

1.11

280

2184

(3013290) Carbon dioxide [Partial pressure] in Blood

299

2401

1.25

3.47

3.5

4.0

5.00

kpa

0.02

290

2356

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

116

811

1.43

3.46

1.0

56.64

42.12

ng/l

0.47

562

(3003181) Sodium [Moles/volume] in Urine

284

2268

1.26

3.46

1.4

64.38

62.19

mmol/l

0.38

236

1810

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

495

1.56

3.45

1.9

1.7

1.35

1.52

u/ml

0.12

127

(3037121) Protein [Mass/volume] in Urine

484

4084

1.19

3.44

3.2

1259.99

413.83

mg/l

0.61

212

1728

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

172

1286

1.34

3.44

2.0

1.8

335.42

373.63

mu/l

0.74

133

1026

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

2.11

3.38

1.8

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

490

4147

1.19

3.38

2.2

4966.74

5065.58

u/l

0.02

176

1615

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

507

4306

1.18

3.36

2.0

1.9

—

(40761536) Microorganisms panel - Urine sediment

1076

9647

1.13

3.36

4.6

4.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

154

1137

1.36

3.36

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

192

1465

1.32

3.35

2.6

3.6

5.44

13.65

nmol/l

0.85

187

1418

(3001964) Herpes simplex virus Ag [Presence] in Specimen

320

1.69

3.35

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

135

976

1.39

3.35

3.3

2.7

26.32

28.02

mg/l

0.17

722

(3002079) Sodium [Moles/time] in 24 hour Urine

571

1.51

3.34

1.2

1.3

157.10

155.43

mmol/24h

0.06

571

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

114

2.20

3.34

1.0

0.03

0.23

u/ml

0.48

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

405

1.61

3.33

2.4

2.6

0.61

mmol/l

0.04

405

(3001686) Cold agglutinin [Titer] in Serum or Plasma

225

1.82

3.31

1.7

1.3

295.25

174.15

titre

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

108

2.22

3.31

1.0

0.11

0.56

u/ml

0.69

(3019225) pH of Specimen

1299

11785

1.11

3.29

4.2

4.3

7.36

0.21

939

8426

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

103

712

1.45

3.29

1.6

1.5

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.64

3.28

1.0

0.58

1.67

u/ml

0.71

(3037692) Legionella sp identified in Specimen by Organism specific culture

425

1.58

3.20

1.3

1.4

—

(3010421) pH of Blood

452

3819

1.19

3.20

3.3

3.6

7.41

0.01

444

3778

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

209

1630

1.29

3.13

6.5

12.00

12.07

mg/l

0.07

198

1516

(3016038) Potassium [Moles/volume] in Urine

116

830

1.40

3.09

1.2

33.97

34.33

mmol/l

0.06

718

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

131

957

1.37

3.08

1.4

1.5

22.25

24.35

u/ml

0.19

176

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.80

3.08

1.4

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

255

2044

1.25

3.06

1.1

—

(3045142) Bone marrow Pathology biopsy report

178

1364

1.31

3.05

1.4

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

255

1.73

2.99

1.5

1.6

0.49

e9/l

0.06

255

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

567

4913

1.16

2.97

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

402

1.57

2.97

2.5

2.0

8.97

9.35

mg/l

0.21

339

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

206

1617

1.28

2.95

1.3

1.4

—

(3011048) Pyruvate [Moles/volume] in Blood

2.47

2.95

1.2

1.3

73.88

78.71

umol/l

0.21

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

313

3785

0.82

2.94

1.1

0.53

0.62

ratio

3.28

506

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

680

1.43

2.92

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

300

2462

1.22

2.91

2.4

2.7

34.10

33.68

umol/l

0.09

269

2225

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

194

1515

1.28

2.90

1.9

2.1

25.83

25.13

mg/l

0.06

550

(3000330) Specific gravity of Urine by Test strip

691

6086

1.14

2.89

3.8

3.4

1.02

ratio

1.51

599

5486

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

156

1.93

2.88

1.1

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

6.67

2.86

1.0

—

(3045424) Erythrocytes [Presence] in Urine

707

6248

1.14

2.82

2.2

0.02

0.17

estimate

0.63

254

1930

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

260

1.69

2.81

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

695

1.41

2.78

1.1

1.08

1.06

ratio

0.31

567

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.57

2.78

1.2

1.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

159

1219

1.31

2.76

2.3

2.1

—

(36303858) Crystals [Presence] in Urine

5.00

2.72

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

176

1373

1.29

2.69

1.6

1.5

3.07

3.79

ug/l

0.44

147

1160

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.33

2.64

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.14

2.64

1.1

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.39

2.62

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

439

1.51

2.62

1.3

1.2

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

246

2003

1.23

2.62

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

189

1495

1.27

2.60

2.2

2.4

0.64

1.21

g/24h

6.10

102

849

(3027456) Digoxin [Moles/volume] in Serum or Plasma

278

2296

1.22

2.58

3.2

3.3

0.76

0.82

nmol/l

2.86

226

1844

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1442

13321

1.09

2.57

3.6

4.2

7.83

23.57

ug/l

4.80

1135

10744

(3004451) EKG impression Narrative

656

1.41

2.56

1.5

1.3

—

(4035726) Immunohistochemistry procedure

1220

11187

1.10

2.56

1.4

—

(3033942) Copper [Moles/time] in 24 hour Urine

2.73

2.54

1.0

1.2

0.39

0.85

umol/24h

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

198

1582

1.26

2.51

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

194

1548

1.26

2.49

4.4

5.4

337.55

365.37

umol/l

1.88

165

1344

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

396

1.52

2.49

1.1

1.2

823.53

920.93

titre

0.31

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

469

1.47

2.49

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

270

1.63

2.48

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

199

1594

1.25

2.48

1.3

1.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.32

2.47

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

217

1.71

2.47

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

110

815

1.35

2.45

1.3

266.67

68.87

titre

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

104

764

1.36

2.44

1.6

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

124

936

1.33

2.44

1.5

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.46

2.44

1.0

1.6

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

303

1.59

2.43

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

498

1.45

2.39

3.0

2.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

173

1370

1.27

2.39

2.0

2.1

6.22

7.67

umol/l

0.67

128

1014

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

376

1.52

2.39

1.1

—

(3017704) Immunofixation for Urine

625

1.39

2.35

1.4

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

253

1.62

2.29

1.2

283.96

330.91

pmol/l

0.52

187

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.37

2.28

1.1

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

113

1.95

2.24

1.2

1.1

—

(3034426) Prothrombin time (PT)

374

1.50

2.23

1.1

1.2

27.54

28.09

0.37

374

(3047189) Immunofixation for 24 hour Urine

556

1.41

2.22

2.0

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

465

1.44

2.21

2.2

2.4

49.31

52.84

umol/l

0.38

406

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

295

1.56

2.20

1.8

1.7

161.16

121.64

au/ml

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

111

839

1.33

2.20

1.4

1.8

91.53

103.66

ng/l

0.31

111

839

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

547

4843

1.14

2.20

2.1

1.9

1.64

2.21

ug/l

0.96

482

4301

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

478

4195

1.14

2.19

4.3

3.8

25.04

24.87

mmol/l

0.76

449

3848

(3002619) Bacteria identified in Specimen by Culture

312

1.54

2.17

1.1

1.2

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

542

1.40

2.17

1.1

1.2

8.42

10.96

mm/h

2.18

542

(3036071) Salmonella sp Ab [Titer] in Serum

361

1.50

2.16

1.2

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

194

1578

1.23

2.15

1.2

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

133

1035

1.29

2.15

1.7

1.8

3.43

3.99

mg/l

0.99

127

991

(3006571) Granulocytes/Leukocytes in Synovial fluid

176

1421

1.24

2.10

1.5

1.6

56.31

56.96

0.07

107

871

(1617658) Protocol used for examination of sentinel lymph nodes

1068

0.73

2.09

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

2.13

2.08

1.1

1.3

0.15

0.16

umol/l

0.28

(3017817) Protein [Mass] in Urine collected for unspecified duration

129

1006

1.29

2.06

2.3

2.6

963.91

974.47

0.02

129

999

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

482

1.41

2.03

1.1

100.74

92.94

1.31

378

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

110

842

1.31

2.03

1.3

100.00

495.96

titre

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

108

827

1.31

1.99

1.1

—

0.57

—

(3043409) Potassium [Moles/volume] in Arterial blood

371

3225

1.15

1.98

4.0

4.4

3.85

3.87

mmol/l

0.35

371

3195

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

119

1.85

1.96

1.0

0.01

0.10

u/ml

1.19

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

602

5406

1.12

1.95

5.6

4.9

1.54

1.61

1.36

578

5126

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

124

971

1.28

1.94

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

606

1.36

1.93

1.5

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

107

823

1.30

1.92

1.6

1.5

7.25

6.92

u/l

0.08

657

(3028679) Herpes simplex virus Ab [Presence] in Serum

633

1.35

1.91

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

3497

33653

1.05

1.90

1.4

—

(3028433) Virus identified in Specimen by Culture

381

1.45

1.88

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

552

4949

1.12

1.85

6.0

5.1

0.89

0.88

0.18

525

4685

(3024263) Appearance of Synovial fluid

585

1.35

1.85

1.5

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

184

1520

1.21

1.81

1.3

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

536

1.36

1.81

1.1

191.23

174.71

iu/ml

0.15

528

(1001926) Buprenorphine [Presence] in Urine by Screen method

342

2980

1.15

1.80

1.6

2.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.06

1.80

1.0

0.01

0.13

u/ml

1.34

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.96

1.79

1.6

1.7

—

(3040893) Potassium [Moles/volume] in Capillary blood

2.76

1.79

2.4

2.0

4.16

4.46

mmol/l

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

184

1.63

1.77

2.0

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

192

1.62

1.77

1.0

93.84

76.08

ug/l

1.44

153

(43055514) Macroprolactin [Presence] in Serum or Plasma

272

1.51

1.75

1.1

1.4

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

404

1.41

1.75

1.1

1.2

20.40

22.93

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

184

1528

1.21

1.73

1.3

1.4

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

117

1470

0.79

1.73

3.9

4.3

37.67

65.80

u/ml

1.53

112

1451

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

1530

1.21

1.71

1.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

533

1.35

1.71

5.0

5.4

53.75

574.78

u/ml

—

(3033099) Centromere Ab [Titer] in Serum

323

1.46

1.70

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

246

2101

1.17

1.70

1.3

39.77

32.02

u/l

0.49

222

1820

(40762887) Creatinine [Moles/volume] in Blood

1.91

1.69

1.1

1.6

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

119

1.77

1.65

2.2

2.9

0.96

1.31

mg/l

0.67

(3013727) Leukocytes other/Leukocytes in Blood

367

0.60

1.64

4.5

3.6

53.20

52.30

0.07

354

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.25

1.63

1.2

1.0

0.03

0.04

u/ml

1.10

(3012565) Volume of 24 hour Urine

591

1.32

1.61

1.9

2.1

1939.92

1921.05

0.06

530

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

411

1.39

1.61

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

188

0.48

1.60

4.7

5.9

15.01

8.25

mmol/l

—

188

(3029634) Reagin Ab [Titer] in Serum by VDRL

179

1496

1.20

1.60

2.2

1.9

0.50

3.81

titre

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

197

1661

1.19

1.60

1.2

1.1

—

3.98

—

(3006462) Nitrate [Presence] in Urine

557

1.33

1.60

3.5

3.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

336

1.43

1.60

1.3

16.47

16.92

umol/l

0.28

295

(3022493) Free Hemoglobin [Mass/volume] in Plasma

480

1.36

1.59

1.8

3.7

65.10

822.21

mg/l

0.79

338

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

145

1188

1.22

1.59

1.2

—

titre

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

337

1.43

1.58

1.7

9.96

9.00

ug/l

0.72

337

(4211845) Urine protein measurement

613

1.31

1.54

3.4

3.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

100

1.80

1.52

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

121

978

1.24

1.52

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.86

1.50

2.7

2.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

109

1.74

1.46

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1381

14611

0.94

1.46

5.3

5.0

33.91

32.73

3.51

967

9782

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.50

1.45

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

838

7784

1.08

1.42

3.3

3.6

48.29

60.17

u/ml

0.72

800

7529

(3005033) Fetal Nuchal fold Thickness US

225

1943

1.16

1.41

1.5

1.26

1.27

0.02

162

1366

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

149

1.61

1.40

1.2

1.3

33.60

56.68

—

(3036782) Glucose [Moles/volume] in Pleural fluid

139

1152

1.21

1.40

1.4

1.3

6.04

6.37

mmol/l

0.73

129

1067

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

165

1.58

1.39

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

238

2735

0.87

1.39

5.9

4.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

189

1.54

1.39

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.89

1.38

1.1

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

624

1.28

1.38

1.2

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

624

1.28

1.38

1.2

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

624

1.28

1.38

1.2

1.9

—

(3036670) Protein [Mass/volume] in Synovial fluid

373

1.37

1.1

1.3

37.37

39.20

g/l

0.38

189

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

239

1.47

1.36

1.4

1.2

216.84

61.92

mg/l

0.44

170

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.94

1.36

1.0

0.00

0.39

u/ml

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

626

1.28

1.35

1.2

1.9

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

1.61

1.34

1.0

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

227

1972

1.15

1.33

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

540

1.30

1.32

2.2

2.1

79.64

147.87

ug/min

0.62

128

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.78

1.32

1.0

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

481

4380

1.10

1.30

1.6

1.5

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.78

1.28

1.0

—

(3016879) Cocaine [Presence] in Urine

396

3574

1.11

1.28

1.6

2.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

310

1.39

1.27

1.2

1.1

—

(44806071) Cardiolipin IgM antibody measurement

162

1.54

1.25

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

617

1.27

1.23

12.4

13.6

0.65

0.63

mmol/l

0.25

565

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.00

1.23

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.00

1.23

1.0

1.1

0.00

0.11

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.91

1.22

1.0

—

(3045788) Cell count panel - Pleural fluid

139

1171

1.19

1.22

1.6

1.5

—

(3023199) Leukocytes [#/volume] in Pleural fluid

169

1448

1.17

1.21

1.6

1.5

10439.92

2819.18

e6/l

0.77

118

1005

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

753

1.24

1.21

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

460

1.31

1.21

1.3

2.1

—

(3017509) Phencyclidine [Presence] in Urine

1.72

1.20

1.5

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

1.83

1.19

1.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

151

1287

1.18

1.17

1.6

1.5

108341.54

56719.20

e6/l

0.49

703

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

368

1.33

1.15

1.1

—

3.67

—

(3013762) Body weight Measured

2.50

1.15

1.2

1.3

—

(21494434) Karyotype in Bone marrow

124

1041

1.19

1.14

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

456

1.30

1.14

1.3

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

456

1.30

1.14

1.3

2.1

—

(3003129) Base excess in Capillary blood by calculation

164

1412

1.16

1.13

2.2

0.53

0.65

mmol/l

0.19

159

1358

(4198724) Urine methamphetamine measurement

388

1.32

1.11

1.8

3.0

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

638

5938

1.08

1.09

4.0

47.23

47.39

0.06

629

5856

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

128

1.56

1.08

1.0

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

161

1.49

1.06

4.5

5.9

45.36

40.31

ug/min

0.12

122

(3043238) Trisomy 21 risk [Likelihood] in Fetus

229

2030

1.13

1.06

1.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

121

1.57

1.05

1.1

1.2

18.45

17.19

g/l

0.32

106

(3024932) HLA-DR beta [Type]

305

1.35

1.04

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

678

1.23

1.04

2.5

2.2

3.24

3.82

ug/l

0.36

629

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.06

1.02

1.1

1.0

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.83

1.02

1.1

1.0

0.19

0.88

u/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

189

1660

1.14

1.02

1.6

1.5

33.96

32.69

g/l

0.74

178

1505

(3038515) Glucose [Moles/volume] in Venous blood

209

2359

0.88

1.01

4.0

3.2

7.50

7.55

mmol/l

0.07

203

2299

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.89

1.01

1.1

1.0

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

181

1587

1.14

1.00

2.1

32.52

32.49

0.03

181

1574

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

546

1.25

1.00

1.1

3.20

14.46

u/ml

—

(4212803) Bone marrow aspirate examination

1.62

0.99

1.0

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

227

2021

1.13

0.99

1.5

1.7

—

(4034850) Laboratory test

401

3679

1.09

0.99

12.7

9.9

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

107

1.59

0.99

1.4

1.3

75.11

118.17

ug/l

—

(3006270) Folate [Moles/volume] in Blood

111

938

1.18

0.99

1.2

399.82

361.53

nmol/l

1.33

803

(3028717) Thiamine [Mass/volume] in Blood

189

1.43

0.98

1.1

1.2

63.33

63.87

ug/l

0.06

189

(3016330) Potassium [Moles/time] in 24 hour Urine

156

1.48

0.98

1.4

1.2

—

87.32

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.67

0.97

1.0

1.1

7.24

12.63

u/l

0.88

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.97

0.0

1.0

—

417.71

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

504

1.25

0.96

1.7

2.0

40.53

39.99

g/l

0.34

504

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.80

0.96

4.2

8.5

108.22

105.08

g/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

111

941

1.18

0.96

1.9

1.8

—

(40768806) Pleura Pathology biopsy report

145

1257

1.16

0.95

1.6

1.5

—

(3010937) Rubella virus Ab [Presence] in Serum

1.69

0.95

1.1

—

(3024471) HLA-A [Type]

311

1.32

0.94

1.0

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

285

1.33

0.94

1.4

1.3

32.72

40.20

0.61

192

(3032057) Clostridioides difficile [Presence] in Stool

242

1.36

0.94

2.0

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.65

0.94

1.5

1.1

—

(3020650) Glucose [Presence] in Urine

408

1.28

0.94

2.1

1.6

0.00

0.04

estimate

1.60

408

(3027273) Bicarbonate [Moles/volume] in Venous blood

570

5321

1.07

0.93

3.3

3.4

25.60

25.25

mmol/l

1.60

551

5145

(4038314) Semen analysis, post vasectomy

2.22

0.93

1.5

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

165

1875

0.88

0.91

1.8

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.14

0.91

1.0

1.1

3.83

3.14

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

666

0.79

0.91

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

420

3880

1.09

0.91

1.6

2.0

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

234

2102

1.12

0.90

1.4

32.14

31.50

u/l

0.09

186

1722

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

384

1.28

0.90

1.7

1.8

2595.60

18039.16

e6/l

1.63

191

(3033086) Enterovirus Ab [Titer] in Serum

2.07

0.89

1.0

—

(37021550) Renin [Units/volume] in Plasma --upright

236

1.36

0.89

1.2

1.3

68.05

73.87

mu/l

0.06

175

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

546

1.23

0.89

2.0

104.00

134.21

umol/l

0.34

287

(3025577) Chromium [Mass/volume] in Blood

655

1.21

0.89

2.7

2.2

2.00

2.55

ug/l

0.86

549

(3028300) Cannabinoids [Presence] in Urine

423

3915

1.08

0.88

1.6

2.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.79

0.87

1.2

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.86

0.87

1.0

—

(3044007) Cell count panel - Peritoneal fluid

387

1.27

0.86

1.8

—

(3020393) Adenovirus Ag [Presence] in Stool

120

1.50

0.85

1.9

1.2

—

(3027008) Opiates [Presence] in Urine

421

3904

1.08

0.85

1.6

1.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

282

1.31

0.84

2.7

3.3

106.23

127.08

ng/l

0.28

120

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.59

0.84

3.3

2.2

0.58

0.63

ug/l

0.28

(3027923) C peptide [Moles/volume] in Serum or Plasma

669

1.20

0.84

1.9

1.5

1.20

1.28

nmol/l

0.27

502

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

345

1.28

0.82

2.2

2.7

72.06

127.56

au/ml

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.69

0.82

1.6

1.5

672.55

464.68

nmol/l

0.54

(3005082) Progesterone [Moles/volume] in Serum or Plasma

552

1.21

0.82

1.4

30.87

36.49

nmol/l

0.62

489

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

146

1.44

0.82

1.1

1.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

417

3874

1.08

0.81

1.4

1.3

207.43

222.35

miu/ml

0.41

197

1778

(3008037) Lactate [Moles/volume] in Venous blood

259

2843

0.91

0.81

3.7

3.1

1.42

1.57

mmol/l

3.19

252

2767

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

356

1.26

0.79

1.2

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

483

1.22

0.78

26.6

28.1

105.09

112.17

ug/l

0.44

394

(3009871) Measles virus Ab [Titer] in Serum

493

1.22

0.77

1.6

5302.86

3212.63

titre

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

843

1.16

0.76

1.3

1.4

0.90

1.18

promille

1.11

666

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

594

1.20

0.76

1.6

1.8

1.84

2.82

u/field

0.93

414

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

107

1.50

0.76

1.1

1.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

503

1.21

0.76

2.0

2.1

31.05

31.21

0.03

503

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.08

0.74

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

378

1.24

0.74

2.7

3.6

8.96

8.39

mg/l

0.27

305

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.84

0.73

1.1

144.59

299.19

nmol/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.84

0.73

1.0

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

1.64

0.73

1.7

4.4

—

(3042733) HLA Ab [Presence] in Serum

325

1.26

0.73

5.4

4.8

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

106

0.57

0.72

1.5

2.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

755

1.17

0.72

1.1

16.42

24.74

u/l

1.82

669

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.58

0.71

1.1

1.0

4.34

4.82

u/ml

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

128

1130

1.13

0.71

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.55

0.69

1.2

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.85

0.68

2.0

2.1

20.94

31.06

—

(3034891) Synovial lining cells/cells in Synovial fluid

565

1.19

0.68

1.4

1.5

6.14

3.62

0.38

109

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

107

937

1.14

0.68

1.3

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

447

1.21

0.67

1.8

2.0

604.24

3754.12

e6/l

0.85

296

(3051387) C reactive protein [Mass/volume] in Capillary blood

224

2445

0.91

0.66

4.0

3.5

22.80

26.91

mg/l

1.16

149

1688

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.79

0.66

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

111

1.44

0.65

1.1

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

1.57

0.65

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

763

1.15

0.65

1.1

71.68

83.05

u/l

1.20

674

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

358

1.23

0.64

1.0

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

198

1.31

0.63

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

198

1.31

0.63

1.1

—

(3048879) Bone marrow aspiration report

337

0.77

0.63

1.2

1.9

—

2.00

—

(3027944) Amphetamines [Presence] in Urine

411

3866

1.07

0.62

1.5

2.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.55

0.62

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

208

1.30

0.61

1.4

1.6

118.04

116.71

ug/l

0.02

180

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

410

3859

1.06

0.61

1.6

1.8

—

28.02

—

(3022670) pH of Venous cord blood

0.00

0.60

0.0

1.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.60

0.0

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

139

1.37

0.60

1.6

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.59

0.0

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

733

1.15

0.58

1.4

1.5

78.31

80.64

umol/l

0.24

733

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

114

0.61

0.57

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

716

1.15

0.57

1.6

1.7

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.48

0.57

3.1

2.2

—

(4146454) Self-monitoring of blood glucose

115

1284

0.89

0.56

2.7

—

(40758358) Immune stain study

1.45

0.56

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

266

1.24

0.55

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

118

1059

1.12

0.55

1.4

1.5

34.33

32.03

0.26

615

(3044242) Glucose [Moles/volume] in Arterial blood

676

0.86

0.54

2.1

2.0

7.35

7.89

mmol/l

0.81

676

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

213

1.27

0.53

1.4

1.5

590.00

5551.30

u/ml

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

276

1.23

0.53

1.1

1.4

27.43

26.29

g/l

0.15

216

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

276

1.23

0.53

1.2

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

244

2271

1.08

0.53

2.0

1.9

0.81

0.85

nmol/l

0.42

211

1915

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

196

1.28

0.52

1.8

2.5

1.21

1.20

mmol/l

0.45

188

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

144

1.32

0.50

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

1030

0.89

0.49

3.5

2.9

33.10

48.18

mg/l

0.49

744

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

198

1.26

0.49

1.1

—

(3000012) Reticulocyte production index

187

1729

1.08

0.49

2.1

0.88

0.91

0.25

130

1148

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

178

0.73

0.48

1.8

1.4

3.88

10.93

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

111

0.63

0.48

1.9

1.1

10.99

9.87

mg/l

—

100

(3026692) Albumin [Mass/volume] in Peritoneal fluid

317

1.20

0.48

1.4

1.5

14.11

13.41

g/l

0.19

250

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

143

0.70

0.47

1.0

1.2

72.40

66.47

ug/l

—

143

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

191

1772

1.08

0.47

1.2

1.1

129.94

6500.88

iu/ml

0.57

386

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

250

2345

1.07

0.46

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

402

1.17

0.46

3.2

3.0

28.01

28.38

umol/l

0.09

307

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.61

0.45

1.4

1.2

1962.80

1251.42

u/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

253

2375

1.07

0.45

1.5

0.97

0.95

ratio

0.27

135

1420

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

253

2375

1.07

0.45

1.5

1.25

1.21

ratio

0.25

136

1427

(3041354) Potassium [Moles/volume] in Venous blood

116

1274

0.91

0.45

2.6

2.3

4.02

4.05

mmol/l

0.32

116

1262

(3004446) Plasmodium sp identified in Blood by Light microscopy

103

1.36

0.45

2.7

2.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

156

1.28

0.45

12.4

12.3

4.80

5.15

mmol/l

0.51

156

(40757373) Influenza virus identified in Isolate

210

1.24

0.44

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

116

1273

0.91

0.44

2.6

2.3

105.17

105.54

mmol/l

0.40

116

1261

(3040151) Glucose [Moles/volume] in Capillary blood

151

1392

1.09

0.44

4.6

10.7

7.64

7.43

mmol/l

0.09

127

1164

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

197

0.76

0.44

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

252

2370

1.06

0.43

1.5

1.16

1.15

ratio

0.08

134

1414

(3044927) Protein electrophoresis panel - Urine

131

1202

1.09

0.43

1.1

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

311

3281

0.95

0.42

1.4

189.79

150.61

pmol/l

0.41

300

3195

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.42

1.0

—

(3020491) Glucose [Moles/volume] in Blood

833

1.11

0.40

1.7

1.9

6.94

6.67

mmol/l

0.41

594

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

172

1602

1.07

0.40

3.8

2.7

13.23

0.01

172

1585

(3036048) Francisella tularensis Ab [Titer] in Serum

268

1.19

0.40

1.1

—

403.08

—

(40765089) Chromosome analysis panel - Blood by G-banded

250

1.20

0.40

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.40

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.40

0.0

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.40

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.40

0.0

2.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

287

1.19

0.40

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

196

1.22

0.39

1.3

1.2

0.87

1.58

mmol/l

0.52

134

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

372

1.16

0.38

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

372

1.16

0.38

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

372

1.16

0.38

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

372

1.16

0.38

1.2

1.1

—

(40768793) Breast Pathology biopsy report

363

3467

1.05

0.38

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

904

1.10

0.38

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

115

1249

0.92

0.38

2.6

2.3

1.20

mmol/l

0.34

115

1237

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

270

2561

1.06

0.37

2.3

2.4

57.16

90.86

ug/min

1.73

149

1489

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

197

1.22

0.37

1.7

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

154

1435

1.07

0.37

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.35

0.37

1.0

1.2

27.60

32.61

umol/24h

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

253

1.19

0.36

5.3

7.3

5.16

5.46

kpa

0.73

253

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

147

1577

0.93

0.36

1.3

7.05

7.34

mmol/l

0.73

135

1394

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

649

1.11

0.36

2.3

2.2

187.44

202.58

u/l

2.12

640

(40768795) Lymph node Pathology biopsy report

142

1322

1.07

0.35

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

281

2674

1.05

0.35

2.6

3.6

259.26

599.25

u/ml

1.37

251

2434

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.43

0.35

1.2

1.1

353.17

274.06

pmol/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

126

1.27

0.35

2.4

2.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

227

1.19

0.34

1.8

2.1

18.02

16.97

umol/l

0.18

227

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

276

0.83

0.34

2.0

1.9

1.88

3.13

ug/l

0.52

157

(3009677) Dengue virus Ab [Presence] in Serum

1.33

0.33

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

294

1.16

0.32

1.1

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

559

1.11

0.32

1.3

1.5

—

1248214.57

iu/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

187

0.80

0.32

1.9

2.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

101

1.29

0.31

1.6

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

126

1177

1.07

0.31

1.4

185917.08

133606.73

e6/l

0.26

783

(3004809) Band form neutrophils/Leukocytes in Blood

197

2075

0.95

0.30

3.2

3.6

1.47

1.56

0.12

180

1866

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

112

1199

0.93

0.28

1.6

1.3

1.66

1.49

nmol/l

0.86

106

1071

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

545

0.90

0.28

2.2

2.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

883

1.08

0.27

1.4

1.3

12.51

14.09

u/l

0.37

809

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.25

0.27

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

522

0.90

0.27

1.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.23

0.27

4.0

3.4

—

(4281824) Cell count and differential, peritoneal fluid

151

1595

0.95

0.26

1.1

—

(3034988) Calcium [Moles/volume] in Capillary blood

206

1.17

0.26

1.8

2.4

1.19

mmol/l

0.04

196

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

253

1.15

0.26

1.1

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.23

0.25

1.2

1.5

416.78

321.86

umol/24h

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.23

0.25

1.1

—

(1761868) Lipid panel - Serum or Plasma

4490

45231

0.99

0.24

3.2

3.1

—

(3026726) Creatinine [Moles/volume] in Specimen

1.25

0.24

4.2

2.4

317.42

420.76

umol/l

0.20

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.73

0.24

1.2

—

(3004775) Volume in Urine collected for unspecified duration

837

0.93

0.23

2.3

677.24

635.93

0.39

570

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.32

0.23

4.8

5.8

350.60

411.34

umol/l

—

(40762365) Oxygen content in Arterial blood by calculation

172

1.16

0.22

2.2

2.9

15.20

14.98

ml/dl

0.14

160

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

33.64

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

20.80

—

(3009992) Blasts/cells in Bone marrow

0.00

0.21

0.0

2.0

—

8.80

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

507

1.09

0.21

1.8

1.5

8.94

1671.49

pmol/l

0.80

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

71.23

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

606

0.92

0.21

1.5

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.4

—

16.29

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

220

2120

1.04

0.21

1.5

1.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

789

1.07

0.20

1.2

1.4

—

(3045462) Protein/Creatinine [Ratio] in Urine

117

1.20

0.20

6.1

3.7

29.34

47.51

mg/mmol

0.79

105

(40765096) Chromosome analysis panel by Banding

376

0.90

0.20

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

130

1239

1.05

0.20

3.0

4.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

183

1.15

0.20

1.4

1.3

—

(40758292) HTLV I+II Ab panel - Serum

221

1.13

0.20

1.2

1.3

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

1.20

0.19

1.0

1.1

0.99

1.15

mom

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

336

1.10

0.19

1.1

1.2

5.21

12.36

pmol/l

—

126

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.18

0.19

1.0

1.2

—

(3017569) Oxygen content in Arterial blood

675

1.07

0.19

2.1

2.3

16.07

15.93

0.17

675

(46235168) Fasting glucose [Moles/volume] in Blood

118

1.19

0.19

1.3

3.2

5.92

7.33

mmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

119

1247

0.95

0.18

2.5

2.4

35.06

25.32

iu/ml

—

148

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.21

0.18

1.6

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

100

1.20

0.18

1.0

—

7.00

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

921

1.05

0.18

2.0

2.44

1.74

u/field

0.53

484

(40762814) Titanium [Mass/volume] in Blood

185

1.14

0.18

3.0

2.3

3.24

3.84

ug/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

776

1.06

0.17

1.2

1.4

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

641

1.06

0.16

1.1

1691.70

1527.08

miu/ml

0.54

641

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

238

2449

0.97

0.16

3.5

3.9

47.48

38.00

u/ml

0.39

230

2370

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

259

2520

1.03

0.16

1.5

63.90

60.15

ug/l

0.50

206

2052

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.11

0.16

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

168

1.13

0.15

1.4

1.3

102.17

232.70

u/l

0.29

120

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.79

0.15

1.0

1.1

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.78

0.15

2.8

4.0

—

0.00

estimate

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

265

0.91

0.14

1.3

1.19

1.17

mmol/l

0.69

265

(3009015) Lactate [Moles/volume] in Synovial fluid

150

0.87

0.14

1.2

4.24

6.45

mmol/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

133

1282

1.04

0.14

1.7

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

160

1.13

0.14

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

131

1356

0.97

0.13

3.5

3.6

58.89

56.92

0.60

120

1166

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

559

0.95

0.12

1.2

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

559

0.95

0.12

1.2

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

286

2917

0.98

0.11

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1236

12468

0.99

0.11

2.0

1.9

3.29

3.39

ratio

2.46

952

9506

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

182

1.10

0.11

3.1

2.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

157

0.89

0.11

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

144

1.11

0.10

1.3

1.6

—

(4133840) Spirometry

280

0.93

0.10

1.2

—

(40768446) Kidney Pathology biopsy report

427

1.05

0.10

1.5

1.6

—

(40763590) HLA-DQ beta [Type]

1.11

0.09

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

166

0.90

0.09

1.1

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

135

1.11

0.09

2.1

3.5

39.67

39.92

umol/l

0.02

116

(46236302) HLA-C [Type] by High resolution typing

1.09

0.09

1.0

—

(40760409) HLA-A [Type] by High resolution

1.09

0.09

1.0

—

(40760410) HLA-B [Type] by High resolution

1.09

0.09

1.0

—

(3013862) HLA-DP [Type]

1.06

0.09

1.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

155

1.10

0.09

1.7

1.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

194

1.08

0.09

5.8

7.0

11.29

10.34

0.89

194

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

292

1.06

0.08

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

175

1.09

0.08

1.1

1.0

7.39

8.06

u/ml

0.05

175

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.82

0.08

1.2

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.81

0.08

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

236

0.93

0.08

1.5

1.2

1.39

1.64

mmol/l

0.62

145

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

918

9247

0.99

0.07

1.7

3.36

3.49

mmol/l

3.20

642

6330

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

0.07

2.9

4.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.85

0.07

1.6

1.3

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

157

1.08

0.07

2.4

2.7

2.17

1.27

mmol/l

—

111

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.86

0.06

1.3

1.1

—

(3016750) Collection duration of Urine

601

1.03

0.06

2.2

2.3

503.50

497.47

min

0.19

453

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

385

0.96

0.05

7.5

3.6

10.19

10.36

kpa

0.14

385

(3014891) Appearance of Pleural fluid

139

1.08

0.05

1.5

1.6

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

141

0.92

0.05

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

384

0.96

0.05

7.5

3.6

4.84

4.98

kpa

0.38

384

(3043410) Blood group antigens tested for on Red Blood Cells

327

1.04

0.05

2.0

1.6

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

120

0.92

0.05

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

437

4396

0.99

0.03

1.5

1.6

1123.38

1005.93

mu/l

1.13

362

3603

(3042517) Benzodiazepines panel - Urine

112

1.07

0.03

1.6

2.4

—

(3019174) dRVVT (LA screen)

103

1.07

0.02

1.1

1.2

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

338

0.98

0.01

1.3

375.93

367.07

ug/l

0.01

183

(3052592) Norovirus Ag [Presence] in Stool

213

1.03

0.01

1.2

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

154

1549

0.99

0.01

1.4

1.5

60.62

59.63

ug/l

0.10

154

1549

(40768441) Liver Pathology biopsy report

938

0.99

0.01

1.5

1.3

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

124

1.05

0.00

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

156

0.96

0.00

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

164

1.04

0.00

1.0

—

(40768800) Prostate Pathology biopsy report

188

1887

1.00

0.00

1.2

—

(3035880) pH of Pleural fluid

616

0.99

0.00

1.4

1.3

7.43

7.41

0.39

413

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

134

0.97

0.00

2.8

2.5

0.54

0.65

u/field

0.20

134

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

206

1.02

0.00

1.4

1.6

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

254

0.98

0.00

2.1

2.5

1329.12

148.07

ug/l

0.42

254

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

286

1.01

0.00

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

238

1.01

0.00

2.7

2.3

6.73

7.63

mmol/l

0.50

151

(40761995) Spermatozoa Progressive [#/volume] in Semen

115

0.96

0.00

4.9

3.0

58.09

43.18

1.08

115

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

115

1.04

0.00

1.8

1.7

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

135

0.96

0.00

1.2

5.86

5.95

mmol/l

0.14

135

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

115

0.96

0.00

9.8

6.0

7.64

8.42

0.13

115

(3029396) Erythrocyte agglutination [Presence] in Blood

273

0.99

0.00

2.6

3.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

513

0.99

0.00

2.9

3.4

1.67

1.29

0.61

513

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

118

1181

1.00

0.00

1.3

—

(3044009) aPTT.lupus sensitive (LA screen)

101

0.99

0.00

1.1

1.3

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.6

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

7.2

—

12.50

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.5

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

0.24

—

(3025504) Homovanillate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.5

—

20.90

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.93

-0.00

1.0

1.4

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.98

-0.00

3.6

5.5

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.99

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.6

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

-0.00

0.0

1.0

—

(3032641) Amino acids panel - Urine

0.00

-0.00

0.0

1.4

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.93

-0.00

4.2

2.6

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_VOICE_DISTU – Voice disturbances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Voice disturbances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Voice disturbances (R18_VOICE_DISTU)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints